Cyclic	O
AMP	O
activates	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
in	O
Th2	B-cell_type
cells	I-cell_type
:	O
phosphorylation	O
of	O
GATA-3	B-protein
and	O
stimulation	O
of	O
Th2	B-cell_type
cytokine	O
gene	O
expression	O
.	O

cAMP	O
is	O
an	O
important	O
second	O
messenger	O
with	O
immunomodulatory	O
properties	O
.	O

Elevation	O
of	O
intracellular	O
cAMP	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
induced	O
by	O
agents	O
such	O
as	O
IL-1alpha	B-protein
or	O
PGs	B-protein
,	O
inhibits	O
T	O
cell	O
activation	O
.	O

In	O
effector	O
T	B-cell_type
cells	I-cell_type
,	O
an	O
increase	O
in	O
the	O
level	O
of	O
intracellular	O
cAMP	O
inhibits	O
cytokine	B-protein
production	O
in	O
Th1	B-cell_type
cells	I-cell_type
but	O
stimulates	O
cytokine	B-protein
production	O
in	O
Th2	B-cell_type
cells	I-cell_type
.	O

Here	O
we	O
report	O
that	O
cAMP-induced	O
effects	O
in	O
Th2	B-cell_type
cells	I-cell_type
occur	O
independently	O
of	O
the	O
protein	B-protein
kinase	I-protein
A	I-protein
pathway	O
,	O
which	O
is	O
the	O
major	O
mediator	O
of	O
cAMP-induced	O
signaling	O
events	O
in	O
most	O
cell	O
types	O
.	O

Instead	O
,	O
cAMP	O
stimulates	O
activation	O
of	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
in	O
Th2	B-cell_type
cells	I-cell_type
.	O

This	O
appears	O
to	O
be	O
a	O
Th2	B-cell_type
-selective	O
event	O
because	O
cAMP	O
barely	O
increased	O
p38	B-protein
phosphorylation	O
in	O
Th1	B-cell_type
cells	I-cell_type
.	O

We	O
show	O
that	O
in	O
Th2	B-cell_type
cells	I-cell_type
,	O
cAMP	O
promotes	O
the	O
production	O
of	O
both	O
IL-5	B-protein
and	O
IL-13	B-protein
,	O
which	O
play	O
distinct	O
but	O
critical	O
roles	O
in	O
asthma	O
pathogenesis	O
.	O

Our	O
data	O
also	O
show	O
that	O
cAMP	O
causes	O
increased	O
phosphorylation	O
of	O
the	O
transcription	B-protein
factor	I-protein
GATA-3	I-protein
,	O
which	O
we	O
have	O
shown	O
is	O
a	O
critical	O
regulator	O
of	O
Th2	B-cell_type
cytokine	O
gene	O
expression	O
and	O
,	O
in	O
turn	O
,	O
of	O
airway	O
inflammation	O
in	O
mice	O
.	O

Thus	O
,	O
Th2	B-cell_type
-specific	O
GATA-3	B-protein
expression	O
and	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
activation	O
together	O
provide	O
a	O
molecular	O
basis	O
for	O
the	O
differential	O
effects	O
of	O
cAMP	O
in	O
the	O
two	O
T	B-cell_type
helper	I-cell_type
cell	I-cell_type
subsets	I-cell_type
.	O

X	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
m	NULL
meJournal	NULL
of	NULL
Cyclic	NULL
AMP	NULL
Activates	NULL
p38	NULL
Mitogen-Activated	NULL
~	NULL
Imnmunolo	NULL
gy	NULL
Protein	NULL
Kinase	NULL
in	NULL
Th2	NULL
Cells	NULL
:	NULL
Phosphorylation	NULL
of	NULL
GATA-3	NULL
and	NULL
Stimulation	NULL
of	NULL
Th2	NULL
Cytokine	NULL
Gene	NULL
Expression	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Chang-Hung	NULL
Chen	NULL
,	NULL
Dong-Hong	NULL
Zhang	NULL
,	NULL
Jody	NULL
M.	NULL
LaPorte	NULL
and	NULL
Anuradha	NULL
Ray	NULL
J	NULL
Immunol	NULL
2000	NULL
;	NULL
165:5597-5605	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.165.10.5597	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/165/10/5597	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
69	NULL
articles	NULL
,	NULL
49	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/165/10/5597.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Cyclic	NULL
AMP	NULL
Activates	NULL
p38	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
in	NULL
Th2	NULL
Cells	NULL
:	NULL
Phosphorylation	NULL
of	NULL
GATA-3	NULL
and	NULL
Stimulation	NULL
of	NULL
Th2	NULL
Cytokine	NULL
Gene	NULL
Expression	NULL
``	NULL
Chang-Hung	NULL
Chen	NULL
,	NULL
Dong-Hong	NULL
Zhang	NULL
,	NULL
Jody	NULL
M.	NULL
LaPorte	NULL
,	NULL
and	NULL
Anuradha	NULL
Ray	NULL
``	NULL
cAMP	NULL
is	NULL
an	NULL
important	NULL
second	NULL
messenger	NULL
with	NULL
immunomodulatory	NULL
properties	NULL
.	NULL

Elevation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
induced	NULL
by	NULL
agents	NULL
such	NULL
as	NULL
IL-1a	NULL
or	NULL
PGs	NULL
,	NULL
inhibits	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
effector	NULL
T	NULL
cells	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
intracellular	NULL
cAMP	NULL
inhibits	NULL
cytokine	NULL
production	NULL
in	NULL
Th1	NULL
cells	NULL
but	NULL
stimulates	NULL
cytokine	NULL
production	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
cAMP-induced	NULL
effects	NULL
in	NULL
Th2	NULL
cells	NULL
occur	NULL
independently	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
A	NULL
pathway	NULL
,	NULL
which	NULL
is	NULL
the	NULL
major	NULL
mediator	NULL
of	NULL
cAMP-induced	NULL
signaling	NULL
events	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
.	NULL

Instead	NULL
,	NULL
cAMP	NULL
stimulates	NULL
activation	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

This	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
Th2-selective	NULL
event	NULL
because	NULL
cAMP	NULL
barely	NULL
increased	NULL
p38	NULL
phosphorylation	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
that	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
cAMP	NULL
promotes	NULL
the	NULL
production	NULL
of	NULL
both	NULL
IL-5	NULL
and	NULL
IL-13	NULL
,	NULL
which	NULL
play	NULL
distinct	NULL
but	NULL
critical	NULL
roles	NULL
in	NULL
asthma	NULL
pathogenesis	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
show	NULL
that	NULL
cAMP	NULL
causes	NULL
increased	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
,	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
is	NULL
a	NULL
critical	NULL
regulator	NULL
of	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
of	NULL
airway	NULL
inflammation	NULL
in	NULL
mice	NULL
.	NULL

Thus	NULL
,	NULL
Th2-specific	NULL
GATA-3	NULL
expression	NULL
and	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
together	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
cAMP	NULL
in	NULL
the	NULL
two	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2000	NULL
,	NULL
165	NULL
;	NULL
5597-5605.	NULL
by	NULL
treatment	NULL
with	NULL
various	NULL
agents	NULL
such	NULL
as	NULL
IL-1a	NULL
@	NULL
,	NULL
PGE	NULL
,	NULL
cholera	NULL
toxin	NULL
,	NULL
forskolin	NULL
or	NULL
by	NULL
direct	NULL
stimulation	NULL
of	NULL
cAMP	NULL
pathways	NULL
with	NULL
dibutyryl	NULL
cAMP	NULL
(	NULL
bt	NULL
,	NULL
cAMP	NULL
)	NULL
®	NULL
,	NULL
inhibits	NULL
IL-2	NULL
and	NULL
IL-2	NULL
receptor	NULL
expression	NULL
thereby	NULL
blocking	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
cell	NULL
proliferation	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

In	NULL
effector	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
elevation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
is	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
Th1	NULL
cytokine	NULL
production	NULL
but	NULL
augmentation	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
intracellular	NULL
cAMP-elevating	NULL
agents	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
IL-12	NULL
production	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
Th2	NULL
cytokines	NULL
,	NULL
IL-5	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
eo-sinophilic	NULL
inflammation	NULL
in	NULL
many	NULL
disease	NULL
states	NULL
,	NULL
including	NULL
asthma	NULL
,	NULL
by	NULL
promoting	NULL
the	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
activation	NULL
,	NULL
and	NULL
survival	NULL
of	NULL
eosinophils	NULL
(	NULL
10-14	NULL
)	NULL
.	NULL

One	NULL
unique	NULL
feature	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
is	NULL
that	NULL
cAMP-elevating	NULL
agents	NULL
such	NULL
as	NULL
IL-1	NULL
«	NULL
@	NULL
,	NULL
forskolin	NULL
,	NULL
and	NULL
PGE	NULL
,	NULL
can	NULL
strongly	NULL
induce	NULL
IL-5	NULL
gene	NULL
expression	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
positive	NULL
regulatory	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
IL-5	NULL
production	NULL
.	NULL

Interestingly	NULL
,	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
region	NULL
reveals	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
transcription	NULL
factors	NULL
including	NULL
GATA-3	NULL
,	NULL
AP-1	NULL
,	NULL
Oct	NULL
,	NULL
Ets	NULL
proteins	NULL
,	NULL
and	NULL
NFAT	NULL
(	NULL
17-19	NULL
)	NULL
but	NULL
no	NULL
cAMP	NULL
response	NULL
el-ement	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
signal	NULL
transduction	NULL
pathways	NULL
I	NULL
:	NULL
levation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
induced	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Section	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520	NULL
Received	NULL
for	NULL
publication	NULL
March	NULL
10	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
August	NULL
25	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
HL60995	NULL
,	NULL
HL	NULL
56843	NULL
,	NULL
and	NULL
P50-HL56389	NULL
(	NULL
to	NULL
A.R	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
of	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Anuradha	NULL
Ray	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Section	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
333	NULL
Cedar	NULL
Street	NULL
,	NULL
LCI	NULL
105	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
anuradha.ray	NULL
@	NULL
yale.edu	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
bt	NULL
,	NULL
cAMP	NULL
,	NULL
dibutyryl	NULL
cAMP	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
PKA	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
ATF	NULL
,	NULL
activating	NULL
transcription	NULL
factor	NULL
;	NULL
MACS	NULL
,	NULL
magnetic-activated	NULL
cell	NULL
sorting	NULL
;	NULL
MFI	NULL
,	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
.	NULL

Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
other	NULL
than	NULL
the	NULL
well	NULL
described	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
pathway	NULL
are	NULL
involved	NULL
in	NULL
cAMP-mediated	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
recent	NULL
years	NULL
,	NULL
considerable	NULL
effort	NULL
has	NULL
been	NULL
mounted	NULL
to	NULL
dissect	NULL
the	NULL
signaling	NULL
events	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Full	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
requires	NULL
at	NULL
least	NULL
two	NULL
signals	NULL
from	NULL
TCR	NULL
and	NULL
costimulatory	NULL
receptors	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Several	NULL
protein	NULL
kinases	NULL
such	NULL
as	NULL
the	NULL
family	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
MAPKs	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
transmission	NULL
of	NULL
extracellular	NULL
signals	NULL
to	NULL
intracellular	NULL
targets	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

TCR	NULL
engagement	NULL
activates	NULL
the	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
pathway	NULL
,	NULL
and	NULL
costimulation	NULL
through	NULL
CD28	NULL
causes	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
activation	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

T	NULL
lymphocyte	NULL
activation	NULL
by	NULL
cAMP	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
down-regulation	NULL
of	NULL
both	NULL
ERK	NULL
and	NULL
JNK	NULL
pathways	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Interruption	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein/extracellular	NULL
signal-related	NULL
kinase	NULL
kinase	NULL
(	NULL
MEK/ERK	NULL
)	NULL
pathway	NULL
with	NULL
the	NULL
phar-macological	NULL
ERK	NULL
inhibitor	NULL
PD98059	NULL
enhanced	NULL
Th2	NULL
cytokine	NULL
(	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
)	NULL
expression	NULL
induced	NULL
by	NULL
PMA/CD3	NULL
or	NULL
by	NULL
CD3/CD28	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
studies	NULL
using	NULL
JNK1-deficient	NULL
mice	NULL
also	NULL
showed	NULL
an	NULL
enhanced	NULL
Th2	NULL
response	NULL
(	NULL
29	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
JINK1	NULL
may	NULL
play	NULL
a	NULL
negative	NULL
role	NULL
in	NULL
ThZ	NULL
cytokine	NULL
production	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
kinases	NULL
ERK	NULL
and	NULL
JNK	NULL
do	NULL
not	NULL
play	NULL
significant	NULL
roles	NULL
in	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
past	NULL
few	NULL
years	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
established	NULL
the	NULL
importance	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
development	NULL
.	NULL

The	NULL
MKK6-p38	NULL
signaling	NULL
pathway	NULL
was	NULL
found	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
negative	NULL
selection	NULL
of	NULL
thymocytes	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
(	NULL
30	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
p38	NULL
inhibitor	NULL
,	NULL
the	NULL
pyridinyl	NULL
imidazole	NULL
$	NULL
B203580	NULL
,	NULL
has	NULL
been	NULL
used	NULL
to	NULL
define	NULL
the	NULL
cellular	NULL
functions	NULL
of	NULL
p38	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
including	NULL
Th1	NULL
and	NULL
Th2	NULL
effector	NULL
cells	NULL
(	NULL
31-36	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
p38	NULL
kinase	NULL
using	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
Abs	NULL
as	NULL
stimuli	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
murine	NULL
T	NULL
cells	NULL
,	NULL
while	NULL
one	NULL
study	NULL
showed	NULL
that	NULL
blockade	NULL
of	NULL
p38	NULL
activity	NULL
partially	NULL
blocks	NULL
TCR-stimulated	NULL
IFN-y	NULL
production	NULL
by	NULL
mouse	NULL
Th1	NULL
cells	NULL
without	NULL
affecting	NULL
Th2	NULL
cytokine	NULL
(	NULL
IL-4	NULL
and	NULL
IL-5	NULL
)	NULL
production	NULL
(	NULL
33	NULL
)	NULL
,	NULL
another	NULL
study	NULL
observed	NULL
reductions	NULL
in	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
production	NULL
by	NULL
inhibition	NULL
of	NULL
p38	NULL
activity	NULL
0022-1767/00/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5598	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
human	NULL
Th2	NULL
effector	NULL
cells	NULL
,	NULL
$	NULL
B203580	NULL
inhibited	NULL
IL-4	NULL
production	NULL
with	NULL
lesser	NULL
effects	NULL
on	NULL
IFN-y	NULL
and	NULL
IL-2	NULL
production	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
substrates	NULL
of	NULL
p38	NULL
include	NULL
the	NULL
transcription	NULL
factors	NULL
activating	NULL
transcription	NULL
factor	NULL
(	NULL
ATF	NULL
)	NULL
-2	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
CHOP	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
,	NULL
and	NULL
MEF2C	NULL
(	NULL
40	NULL
)	NULL
and	NULL
the	NULL
kinases	NULL
MAPKAP-2	NULL
and	NULL
-3	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
physiological	NULL
substrate	NULL
(	NULL
s	NULL
)	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
T	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
signaling	NULL
events	NULL
after	NULL
stimulation	NULL
of	NULL
murine	NULL
Th2	NULL
effector	NULL
cells	NULL
by	NULL
cAMP	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
cAMP-induced	NULL
effects	NULL
in	NULL
Th2	NULL
cells	NULL
are	NULL
independent	NULL
of	NULL
the	NULL
PKA	NULL
pathway	NULL
but	NULL
instead	NULL
are	NULL
mediated	NULL
by	NULL
p38	NULL
MAPK	NULL
.	NULL

This	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
Th2-selective	NULL
event	NULL
because	NULL
cAMP	NULL
barely	NULL
increased	NULL
p38	NULL
kinase	NULL
activity	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
that	NULL
cAMP	NULL
not	NULL
only	NULL
promotes	NULL
IL-5	NULL
production	NULL
but	NULL
also	NULL
increases	NULL
expression	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
show	NULL
that	NULL
cAMP	NULL
causes	NULL
increased	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
,	NULL
which	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
previously	NULL
,	NULL
is	NULL
a	NULL
critical	NULL
regulator	NULL
of	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
of	NULL
airway	NULL
inflammation	NULL
in	NULL
vivo	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
phosphorylation	NULL
of	NULL
GATA-3	NULL
by	NULL
active	NULL
p38	NULL
MAPK	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
differential	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
Th1	NULL
and	NULL
Th2	NULL
cytokine	NULL
production	NULL
can	NULL
be	NULL
,	NULL
at	NULL
least	NULL
partly	NULL
,	NULL
explained	NULL
by	NULL
differential	NULL
induction	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
Th2	NULL
cells	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
triggers	NULL
phosphorylation	NULL
of	NULL
GATA-3	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Nuclear	NULL
run-on	NULL
transcription	NULL
analysis	NULL
Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
5	NULL
X	NULL
10	NULL
``	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
D10	NULL
cells	NULL
,	NULL
suspended	NULL
in	NULL
nuclear	NULL
storage	NULL
buffer	NULL
(	NULL
40	NULL
%	NULL
glycerol	NULL
;	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
;	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
;	NULL
0.1	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
quick	NULL
frozen	NULL
in	NULL
a	NULL
dry	NULL
ice-methanol	NULL
bath	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
further	NULL
use	NULL
.	NULL

Thawed	NULL
nuclei	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
%	NULL
glycerol	NULL
;	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
;	NULL
100	NULL
mM	NULL
KCI	NULL
;	NULL
4.5	NULL
mM	NULL
MgCl	NULL
;	NULL
2	NULL
mM	NULL
DTT	NULL
;	NULL
0.4	NULL
mM	NULL
each	NULL
of	NULL
ATP	NULL
,	NULL
GTP	NULL
,	NULL
and	NULL
CTP	NULL
;	NULL
and	NULL
100	NULL
Ci	NULL
of	NULL
[	NULL
a	NULL
«	NULL
-*P	NULL
]	NULL
UTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Transcription	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
pl	NULL
of	NULL
termination	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
;	NULL
0.5	NULL
M	NULL
NaCl	NULL
;	NULL
5	NULL
mM	NULL
EDTA	NULL
;	NULL
2	NULL
U	NULL
DNase	NULL
I	NULL
;	NULL
40	NULL
U	NULL
RNasin	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WID	NULL
)	NULL
;	NULL
and	NULL
incubating	NULL
at	NULL
30°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Transcripts	NULL
were	NULL
isolated	NULL
by	NULL
Trizol	NULL
LS	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Unincorporated	NULL
radioactivity	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
final	NULL
RNA	NULL
pellets	NULL
using	NULL
spin	NULL
columns	NULL
,	NULL
and	NULL
the	NULL
incorporated	NULL
radioactivity	NULL
was	NULL
counted	NULL
by	NULL
liquid	NULL
scintillation	NULL
.	NULL

Equal	NULL
counts	NULL
of	NULL
radiolabeled	NULL
RNA	NULL
were	NULL
hybridized	NULL
to	NULL
cDNAs	NULL
linearized	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
enzymes	NULL
and	NULL
immobilized	NULL
as	NULL
slots	NULL
on	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
using	NULL
Trizol	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

A	NULL
~450-bp	NULL
Sacl-Accl	NULL
fragment	NULL
of	NULL
murine	NULL
IL-5	NULL
cDNA	NULL
was	NULL
labeled	NULL
with	NULL
using	NULL
a	NULL
Random	NULL
Primer	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
using	NULL
QuikHyb	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Analysis	NULL
of	NULL
MAPK	NULL
activation	NULL
Rested	NULL
Th2	NULL
cells	NULL
(	NULL
D10	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
Bruff	NULL
's	NULL
medium	NULL
containing	NULL
0.5	NULL
%	NULL
FBS	NULL
for	NULL
3	NULL
h	NULL
to	NULL
reduce	NULL
background	NULL
phosphorylation	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
H89	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulating	NULL
with	NULL
cAMP	NULL
or	NULL
forskolin	NULL
.	NULL

Twenty	NULL
minutes	NULL
after	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
,	NULL
pH	NULL
7.4	NULL
;	NULL
250	NULL
mM	NULL
NaCl	NULL
;	NULL
2	NULL
mM	NULL
EDTA	NULL
;	NULL
50	NULL
mM	NULL
NaF	NULL
;	NULL
0.1	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
;	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
and	NULL
protease	NULL
inhibitors	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
insoluble	NULL
cell	NULL
debris	NULL
was	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
4°C	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
in	NULL
cell	NULL
lysates	NULL
was	NULL
determined	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
suspended	NULL
in	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
,	NULL
fractionated	NULL
on	NULL
4-20	NULL
%	NULL
gradient	NULL
SDS	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
Bio-Rad	NULL
)	NULL
,	NULL
and	NULL
transferred	NULL
onto	NULL
polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
individual	NULL
MAPKs	NULL
,	NULL
p38	NULL
,	NULL
ERK	NULL
,	NULL
and	NULL
JNK	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
TBST	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
subsequently	NULL
incu-	NULL
cAMP	NULL
ACTIVATES	NULL
P38	NULL
MAPK	NULL
IN	NULL
TH2	NULL
CELLS	NULL
bated	NULL
with	NULL
rabbit	NULL
anti-phospho-p38	NULL
,	NULL
anti-phospho-ERK	NULL
,	NULL
and	NULL
anti-phospho-JNK	NULL
Abs	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
followed	NULL
by	NULL
anti-rabbit	NULL
IgG-HRP	NULL
conjugate	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
similar	NULL
protein	NULL
loading	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
the	NULL
phospho	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
the	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
Abs	NULL
against	NULL
p38	NULL
,	NULL
ERK	NULL
,	NULL
and	NULL
JNK	NULL
.	NULL

To	NULL
examine	NULL
kinase	NULL
activation	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
derived	NULL
from	NULL
primary	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
prepared	NULL
by	NULL
positive	NULL
selection	NULL
using	NULL
mAbs	NULL
to	NULL
CD4	NULL
coupled	NULL
to	NULL
magnetic	NULL
and	NULL
a	NULL
magnetic-activated	NULL
cell	NULL
sorting	NULL
(	NULL
MACS	NULL
)	NULL
separation	NULL
column-beads	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Syngeneic	NULL
T	NULL
cell-depleted	NULL
splenocytes	NULL
were	NULL
used	NULL
as	NULL
APCs	NULL
,	NULL
which	NULL
were	NULL
prepared	NULL
by	NULL
depletion	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
using	NULL
Ab-coupled	NULL
magnetic	NULL
beads	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
subsequently	NULL
treated	NULL
with	NULL
mitomycin	NULL
C.	NULL
Cultures	NULL
were	NULL
set	NULL
up	NULL
in	NULL
flasks	NULL
containing	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
together	NULL
with	NULL
pOVA*	NULL
``	NULL
``	NULL
***	NULL
``	NULL
(	NULL
5	NULL
g/tol	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
,	NULL
anti-IL-4	NULL
and	NULL
IL-12	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
Th1	NULL
polarization	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
and	NULL
IL-4	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
for	NULL
Th2	NULL
polarization	NULL
for	NULL
7	NULL
days	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
stimulated	NULL
with	NULL
bt	NULL
;	NULL
cAMP	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPK	NULL
was	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Analysis	NULL
of	NULL
cytokine	NULL
production	NULL
D10	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
kinase	NULL
inhibitor	NULL
(	NULL
SB203580	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
and	NULL
brefeldin	NULL
A	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
IL-5	NULL
production	NULL
was	NULL
evaluated	NULL
by	NULL
intracellular	NULL
staining	NULL
procedures	NULL
.	NULL

After	NULL
washing	NULL
twice	NULL
in	NULL
staining	NULL
buffer	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
and	NULL
permeabilized	NULL
with	NULL
Cytofix/Cytoperm	NULL
solution	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

PE-anti-IL-5	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
cytokine	NULL
expression	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
FACS	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
forward	NULL
scatter	NULL
and	NULL
side	NULL
scatter	NULL
properties	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
used	NULL
to	NULL
exclude	NULL
dead	NULL
cells	NULL
from	NULL
the	NULL
analysis	NULL
.	NULL

Spleens	NULL
were	NULL
harvested	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
and	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
positive	NULL
selection	NULL
using	NULL
mAbs	NULL
to	NULL
CD4	NULL
coupled	NULL
to	NULL
magnetic	NULL
beads	NULL
(	NULL
MACS	NULL
;	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
and	NULL
a	NULL
MACS	NULL
separation	NULL
column	NULL
.	NULL

Syngeneic	NULL
T	NULL
cell-depleted	NULL
splenocytes	NULL
were	NULL
used	NULL
as	NULL
APCs	NULL
,	NULL
which	NULL
were	NULL
prepared	NULL
by	NULL
depletion	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
using	NULL
Ab-coupled	NULL
magnetic	NULL
beads	NULL
(	NULL
MACS	NULL
;	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
subsequently	NULL
treated	NULL
with	NULL
mitomycin	NULL
C.	NULL
Cultures	NULL
were	NULL
set	NULL
up	NULL
in	NULL
flasks	NULL
containing	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
together	NULL
with	NULL
pOVA**	NULL
>	NULL
°	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
,	NULL
anti-IFN-y	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
for	NULL
7	NULL
days	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA~+bt	NULL
,	NULL
cAMP	NULL
or	NULL
PMA+	NULL
ionomycin	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
or	NULL
IL-13	NULL
.	NULL

The	NULL
lower	NULL
limits	NULL
of	NULL
detection	NULL
for	NULL
the	NULL
cytokines	NULL
were	NULL
IL-4	NULL
,	NULL
5	NULL
pg/ml	NULL
;	NULL
IL-5	NULL
,	NULL
5	NULL
pg/ml	NULL
(	NULL
Endogen	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
;	NULL
and	NULL
IL-13	NULL
,	NULL
1.5	NULL
pg/ml	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Transfection	NULL
assays	NULL
IL-5	NULL
and	NULL
IL-4	NULL
reporter	NULL
constructs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
43	NULL
)	NULL
.	NULL

For	NULL
the	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
-Luc	NULL
construct	NULL
,	NULL
the	NULL
GATA	NULL
binding	NULL
doublet	NULL
present	NULL
in	NULL
the	NULL
IL-5	NULL
--	NULL
-	NULL
>	NULL
promoter	NULL
(	NULL
CTATCTGATTG	NULL
)	NULL
was	NULL
dimerized	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
minimal	NULL
e__	NULL
IL-5	NULL
promoter	NULL
(	NULL
5	NULL
'	NULL
border	NULL
at	NULL
-40	NULL
)	NULL
using	NULL
Bgi/lI	NULL
and	NULL
BamHI	NULL
introduced	NULL
into	NULL
PCR	NULL
primers	NULL
as	NULL
cloning	NULL
sites	NULL
.	NULL

Rested	NULL
D10	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
and	NULL
resuspended	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
and	NULL
transfections	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
and	NULL
then	NULL
diluted	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
Bruff	NULL
's	NULL
medium	NULL
at	NULL
37°C	NULL
overnight	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
20	NULL
h	NULL
poststimulation	NULL
with	NULL
PMA+bt	NULL
;	NULL
cAMP	NULL
or	NULL
PMA+ionomycin	NULL
for	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

Cell	NULL
labeling	NULL
and	NULL
immunoprecipitation	NULL
D10	NULL
cells	NULL
were	NULL
starved	NULL
in	NULL
phosphorus-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
dialysed	NULL
FCS	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
*°P-labeled	NULL
orthophosphate	NULL
(	NULL
10	NULL
mCi/ml	NULL
,	NULL
ICN	NULL
Pharmaceuticals	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
(	NULL
1	NULL
mCi/10	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
bt	NULL
,	NULL
cAMP	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h.	NULL
Cells	NULL
were	NULL
washed	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
%	NULL
g	NULL
for	NULL
10	NULL
min	NULL
to	NULL
remove	NULL
cell	NULL
debris	NULL
.	NULL

GATA-3	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
agarose-conjugated	NULL
monoclonal	NULL
anti-GATA-3	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
by	NULL
incubation	NULL
at	NULL
4°C	NULL
overnight	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
washing	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
0.1	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
protease	NULL
inhibitor	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
boiled	NULL
in	NULL
2X	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
stained	NULL
by	NULL
Coomassie	NULL
blue	NULL
before	NULL
autoradiography	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Production	NULL
of	NULL
recombinant	NULL
GATA-3	NULL
and	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
An	NULL
EcoRUXbal	NULL
(	NULL
tagged	NULL
by	NULL
PCR	NULL
)	NULL
fragment	NULL
of	NULL
murine	NULL
GATA-3	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
insect	NULL
cell	NULL
expression	NULL
vector	NULL
pIZT/V5.His	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
express	NULL
recombinant	NULL
GATA-3	NULL
protein	NULL
,	NULL
Sf9	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
construct	NULL
pIZT/G3.V5.His	NULL
using	NULL
the	NULL
insectinPlus	NULL
transfection	NULL
kit	NULL
(	NULL
Invitrogen	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Protein	NULL
expression	NULL
was	NULL
monitored	NULL
by	NULL
GFP	NULL
expression	NULL
,	NULL
and	NULL
,	NULL
at	NULL
60	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
GATA-3	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
using	NULL
a	NULL
nickel-chelated	NULL
column	NULL
.	NULL

To	NULL
perform	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
GATA-3	NULL
fusion	NULL
protein	NULL
or	NULL
10	NULL
pug	NULL
of	NULL
rATF-2	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
was	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
active	NULL
p38	NULL
MAPK	NULL
(	NULL
Stratagene	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
Ci	NULL
of	NULL
(	NULL
>	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
}	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
the	NULL
phosphorylated	NULL
GATA-3	NULL
fusion	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
anti-GATA-3	NULL
Ab	NULL
,	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
gels	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
Phosphorim-ager	NULL
(	NULL
Cyclone	NULL
;	NULL
Packard	NULL
,	NULL
Meriden	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Results	NULL
Induction	NULL
of	NULL
IL-5	NULL
mRNA	NULL
expression	NULL
by	NULL
cAMP	NULL
is	NULL
PKA	NULL
independent	NULL
in	NULL
Th2	NULL
effector	NULL
cells	NULL
To	NULL
determine	NULL
whether	NULL
cAMP	NULL
induces	NULL
nascent	NULL
transcription	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
,	NULL
nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
conducted	NULL
.	NULL

The	NULL
mitogen	NULL
Con	NULL
A	NULL
,	NULL
which	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
both	NULL
Con	NULL
A	NULL
and	NULL
bt	NULL
,	NULL
cAMP	NULL
induced	NULL
new	NULL
transcription	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
in	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
cells	NULL
.	NULL

Because	NULL
PKA	NULL
is	NULL
the	NULL
major	NULL
mediator	NULL
of	NULL
cAMP-induced	NULL
effects	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
we	NULL
first	NULL
investigated	NULL
its	NULL
role	NULL
in	NULL
cAMP-induced	NULL
IL-5	NULL
mRNA	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
cAMP-induced	NULL
IL-5	NULL
gene	NULL
expression	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
was	NULL
not	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
PKA	NULL
inhibitor	NULL
H89	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
HA10O4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
PKA	NULL
pathway	NULL
is	NULL
not	NULL
critical	NULL
for	NULL
cAMP-mediated	NULL
IL-5	NULL
production	NULL
in	NULL
Th2	NULL
effector	NULL
cells	NULL
.	NULL

How	NULL
A	NULL
(	NULL
D10	NULL
)	NULL
¢	NULL
¢	NULL
073	NULL
}	NULL
w	NULL
00°	NULL
owl	NULL
«	NULL
#	NULL
»	NULL
-	NULL
a	NULL
|	NULL
iL-S	NULL
BSK	NULL
<	NULL
one	NULL
wane	NULL
_	NULL
«	NULL
mm	NULL
GAPDH	NULL
B	NULL
(	NULL
D10	NULL
)	NULL
(	NULL
EL4	NULL
)	NULL
bi	NULL
,	NULL
cAMP	NULL
-	NULL
O+	NULL
+	NULL
+	NULL
bt	NULL
;	NULL
CAMP	NULL
-	NULL
09	NULL
>	NULL
+	NULL
+	NULL
+	NULL
Hgg	NULL
-	NULL
-	NULL
--	NULL
-	NULL
eg	NULL
-	NULL
+	NULL
-	NULL
_	NULL
-_	NULL
<	NULL
4-	NULL
IL-5	NULL
¢	NULL
|	NULL
``	NULL
|	NULL
1	NULL
170	NULL
2ss	NULL
ma	NULL
l	NULL
--	NULL
--	NULL
-	NULL
185	NULL
rRNA	NULL
FIGURE	NULL
1.	NULL
cAMP	NULL
induces	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
through	NULL
a	NULL
PKA-independent	NULL
signaling	NULL
pathway	NULL
.	NULL

A	NULL
,	NULL
Nuclear	NULL
run-on	NULL
analysis	NULL
of	NULL
IL-5	NULL
gene	NULL
transcription	NULL
induced	NULL
by	NULL
bt	NULL
,	NULL
cAMP	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
D10	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
Con	NULL
A	NULL
(	NULL
5	NULL
ug/l	NULL
)	NULL
or	NULL
bt	NULL
,	NULL
cAMP	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
.	NULL

Nascent	NULL
RNA	NULL
molecules	NULL
initiated	NULL
in	NULL
vivo	NULL
were	NULL
P-labeled	NULL
by	NULL
elongation	NULL
in	NULL
vitro	NULL
in	NULL
isolated	NULL
nuclei	NULL
.	NULL

Equal	NULL
counts	NULL
of	NULL
radiolabeled	NULL
RNA	NULL
were	NULL
hybridized	NULL
to	NULL
cDNAs	NULL
linearized	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
enzymes	NULL
and	NULL
immobilized	NULL
as	NULL
slots	NULL
on	NULL
nylon	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
Bluescript	NULL
plasmid	NULL
(	NULL
BSK	NULL
;	NULL
Strat-agene	NULL
)	NULL
is	NULL
illustrative	NULL
of	NULL
nonspecific	NULL
binding	NULL
,	NULL
whereas	NULL
the	NULL
GAPDH	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
equal	NULL
RNA	NULL
counts	NULL
applied	NULL
to	NULL
each	NULL
slot	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
washed	NULL
,	NULL
and	NULL
specific	NULL
binding	NULL
was	NULL
evaluated	NULL
by	NULL
autoradiography	NULL
.	NULL

B	NULL
,	NULL
D10	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
alone	NULL
,	NULL
whereas	NULL
ELA	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
bt	NULL
,	NULL
cAMP	NULL
for	NULL
6	NULL
h	NULL
after	NULL
preincubation	NULL
with	NULL
H89	NULL
(	NULL
0.5	NULL
and	NULL
1	NULL
uM	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
techniques	NULL
.	NULL

#	NULL
80-	NULL
:	NULL
5599	NULL
ever	NULL
,	NULL
the	NULL
PKA	NULL
signaling	NULL
pathway	NULL
was	NULL
previously	NULL
implicated	NULL
in	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
the	NULL
murine	NULL
thymoma	NULL
line	NULL
EL-4	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
PKA	NULL
in	NULL
EL-4	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
efficiently	NULL
activate	NULL
the	NULL
IL-5	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phorbol	NULL
ester	NULL
(	NULL
45	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
PKA	NULL
pathway	NULL
in	NULL
EL-4	NULL
cells	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
our	NULL
experiments	NULL
where	NULL
PMA-	NULL
and	NULL
bt	NULL
,	NULL
cAMP-stimulated	NULL
IL-5	NULL
mRNA	NULL
expression	NULL
was	NULL
potently	NULL
inhibited	NULL
by	NULL
H89	NULL
.	NULL

Thus	NULL
,	NULL
unlike	NULL
in	NULL
EL-4	NULL
cells	NULL
,	NULL
cAMP	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
efficiently	NULL
activate	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
without	NULL
dependence	NULL
on	NULL
the	NULL
PKA	NULL
signaling	NULL
pathway	NULL
.	NULL

cAMP	NULL
activates	NULL
p38	NULL
MAPK	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
Th1	NULL
cells	NULL
The	NULL
MAPKs	NULL
,	NULL
p38	NULL
,	NULL
JNK	NULL
,	NULL
and	NULL
ERK	NULL
,	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

cAMP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
JNK	NULL
and	NULL
ERK	NULL
activation	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Jurkat	NULL
and	NULL
ELA	NULL
cells	NULL
)	NULL
(	NULL
27	NULL
,	NULL
46	NULL
)	NULL
,	NULL
but	NULL
no	NULL
study	NULL
has	NULL
yet	NULL
addressed	NULL
the	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
p38	NULL
MAPK	NULL
activation	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
MAPKs	NULL
in	NULL
D10	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
a	NULL
low	NULL
level	NULL
of	NULL
basal	NULL
phospho-p38	NULL
was	NULL
detected	NULL
in	NULL
D10	NULL
cells	NULL
,	NULL
and	NULL
stimulation	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
enhanced	NULL
p38	NULL
phosphorylation	NULL
.	NULL

However	NULL
,	NULL
bt	NULL
,	NULL
cAMP	NULL
did	NULL
not	NULL
induce	NULL
phosphorylation	NULL
of	NULL
either	NULL
ERK	NULL
or	NULL
JNK	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
JNK	NULL
decreased	NULL
slightly	NULL
after	NULL
cAMP	NULL
stimulation	NULL
.	NULL

Our	NULL
initial	NULL
examination	NULL
of	NULL
the	NULL
kinetics	NULL
of	NULL
phosphorylation	NULL
showed	NULL
optimal	NULL
p38	NULL
phosphorylation	NULL
at	NULL
20	NULL
min	NULL
poststimulation	NULL
;	NULL
therefore	NULL
,	NULL
this	NULL
time	NULL
point	NULL
was	NULL
chosen	NULL
in	NULL
all	NULL
subsequent	NULL
experiments	NULL
.	NULL

We	NULL
did	NULL
not	NULL
detect	NULL
ERK	NULL
or	NULL
JNK	NULL
phosphorylation	NULL
at	NULL
any	NULL
of	NULL
the	NULL
other	NULL
time	NULL
points	NULL
examined	NULL
(	NULL
from	NULL
1	NULL
to	NULL
60	NULL
min	NULL
of	NULL
stimulation	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
cAMP	NULL
preferentially	NULL
activates	NULL
p38	NULL
kinase	NULL
but	NULL
not	NULL
ERK	NULL
or	NULL
JNK	NULL
.	NULL

Forskolin	NULL
,	NULL
which	NULL
elevates	NULL
intracellular	NULL
cAMP	NULL
by	NULL
stimulating	NULL
adenylate	NULL
cyclase	NULL
,	NULL
also	NULL
enhanced	NULL
p38	NULL
phosphorylation	NULL
in	NULL
D10	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
H89	NULL
,	NULL
there	NULL
was	NULL
no	NULL
effect	NULL
on	NULL
cAMP-	NULL
or	NULL
forskolin-induced	NULL
p38	NULL
phosphorylation	NULL
.	NULL

If	NULL
anything	NULL
,	NULL
H89	NULL
enhanced	NULL
p38	NULL
phosphorylation	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
PKA	NULL
pathway	NULL
and	NULL
the	NULL
p38	NULL
MAPK	NULL
signaling	NULL
pathway	NULL
are	NULL
mutually	NULL
antagonistic	NULL
in	NULL
Th2	NULL
cells	NULL
such	NULL
that	NULL
inhibition	NULL
of	NULL
the	NULL
PKA	NULL
pathway	NULL
raises	NULL
the	NULL
basal	NULL
phosphorylation	NULL
of	NULL
p38	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggested	NULL
that	NULL
cAMP	NULL
induces	NULL
p38	NULL
MAPK	NULL
in	NULL
Th2	NULL
cells	NULL
in	NULL
a	NULL
PKA-independent	NULL
fashion	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
this	NULL
cAMP-induced	NULL
p38	NULL
phosphorylation	NULL
is	NULL
Th2	NULL
specific	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
p38	NULL
phosphorylation	NULL
in	NULL
Th1	NULL
cells	NULL
using	NULL
the	NULL
Th1	NULL
clone	NULL
,	NULL
A.E7	NULL
.	NULL

Addition	NULL
of	NULL
bt	NULL
,	NULL
cAMP	NULL
only	NULL
marginally	NULL
augmented	NULL
p38	NULL
phosphorylation	NULL
in	NULL
Th1	NULL
cells	NULL
and	NULL
,	NULL
unlike	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
H89	NULL
reduced	NULL
phospho-p38	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cAMP	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
essentially	NULL
the	NULL
same	NULL
at	NULL
other	NULL
time	NULL
points	NULL
post	NULL
stimulation	NULL
.	NULL

The	NULL
Th2-specific	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
generated	NULL
by	NULL
differentiation	NULL
of	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
cAMP-induced	NULL
p38	NULL
phosphorylation	NULL
is	NULL
a	NULL
Th2-specific	NULL
event	NULL
and	NULL
strongly	NULL
suggest	NULL
that	NULL
cAMP-induced	NULL
signaling	NULL
pathways	NULL
are	NULL
distinct	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
is	NULL
the	NULL
dominant	NULL
cAMP-induced	NULL
signaling	NULL
pathway	NULL
stimulated	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAPK	NULL
inhibits	NULL
cAMP	NULL
-induced	NULL
IL-5	NULL
and	NULL
IL-13	NULL
production	NULL
in	NULL
Th2	NULL
cells	NULL
Having	NULL
observed	NULL
the	NULL
Th2-specific	NULL
activation	NULL
of	NULL
p38	NULL
kinase	NULL
by	NULL
cAMP	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
this	NULL
kinase	NULL
in	NULL
cAMP	NULL
-induced	NULL
IL-5	NULL
gene	NULL
expression	NULL
.	NULL

D1O	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
cAMP	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
IL-5	NULL
protein	NULL
production	NULL
in	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
was	NULL
estimated	NULL
by	NULL
intracellular	NULL
staining	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
unstimulated	NULL
cells	NULL
displayed	NULL
a	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
MFT	NULL
)	NULL
of	NULL
<	NULL
35	NULL
,	NULL
whereas	NULL
64	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
had	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5600	NULL
cAMP	NULL
ACTIVATES	NULL
P38	NULL
MAPK	NULL
IN	NULL
TH2	NULL
CELLS	NULL
A	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
C	NULL
Thi	NULL
(	NULL
AE7	NULL
)	NULL
btpsAMP	NULL
-	NULL
_	NULL
%	NULL
*	NULL
btacAMP	NULL
-	NULL
e	NULL
phospho	NULL
p38	NULL
se	NULL
H89g	NULL
-~	NULL
*	NULL
*	NULL
phospho	NULL
p38	NULL
FIGURE	NULL
2.	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
ERK	NULL
or	NULL
JNK	NULL
,	NULL
is	NULL
p36	NULL
|	NULL
«	NULL
«	NULL
«	NULL
»	NULL
activated	NULL
by	NULL
cAMP	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
D10	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
bt	NULL
;	NULL
cAMP	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
phos-	NULL
phospho	NULL
ERK	NULL
p38	NULL
|	NULL
a	NULL
ware	NULL
mth	NULL
phorylations	NULL
of	NULL
p38	NULL
,	NULL
ERK	NULL
,	NULL
and	NULL
JNK	NULL
were	NULL
detected	NULL
by	NULL
probing	NULL
with	NULL
the	NULL
specific	NULL
anti-phospho-kinase	NULL
Ab	NULL
.	NULL

The	NULL
same	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
anti-	NULL
ERK	NULL
kinase	NULL
Ab	NULL
.	NULL

B	NULL
,	NULL
D10	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
or	NULL
forskolin	NULL
(	NULL
10	NULL
M	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
H89	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
.	NULL

Phospho-p38	NULL
was	NULL
detected	NULL
as	NULL
in	NULL
A	NULL
.	NULL

C	NULL
,	NULL
AE7	NULL
cells	NULL
phospho	NULL
JNK	NULL
‘	NULL
E	NULL
D	NULL
DO11.10	NULL
TCR	NULL
Tg	NULL
(	NULL
Ova	NULL
)	NULL
Mice	NULL
Th1	NULL
Th2	NULL
(	NULL
Th1	NULL
cells	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
in	NULL
the	NULL
cap	NULL
Com	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
H89	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

To-	NULL
JNK	NULL
|	NULL
``	NULL
°	NULL
2	NULL
-	NULL
+0	NULL
-	NULL
+	NULL
tal	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
as	NULL
in	NULL
A	NULL
.	NULL

D	NULL
,	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
were	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
DO11.10	NULL
mice	NULL
.	NULL

After	NULL
6	NULL
days	NULL
,	NULL
the	NULL
primed	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
phospho	NULL
p38	NULL
restimulated	NULL
with	NULL
bt	NULL
,	NULL
cAMP	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Total	NULL
cell	NULL
EE	NULL
Ed	NULL
<	NULL
umes	NULL
lysates	NULL
were	NULL
harvested	NULL
and	NULL
used	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
B	NULL
Th2	NULL
(	NULL
D1	NULL
0	NULL
)	NULL
P	NULL
®	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPK	NULL
as	NULL
in	NULL
A	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
Forskolin	NULL
_	NULL
_	NULL
%	NULL
%	NULL
experiments	NULL
.	NULL

bt	NULL
20	NULL
AMP	NULL
Boge	NULL
2	NULL
2	NULL
HBQ	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
O+	NULL
phospho	NULL
p38	NULL
--	NULL
-	NULL
@	NULL
me	NULL
me	NULL
d-	NULL
-as	NULL
pid	NULL
«	NULL
sav	NULL
o	NULL
c-	NULL
up	NULL
-o	NULL
come	NULL
a	NULL
MFI	NULL
of	NULL
>	NULL
100	NULL
in	NULL
cAMP-stimulated	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
$	NULL
B203580	NULL
IL-5	NULL
production	NULL
was	NULL
greatly	NULL
reduced	NULL
,	NULL
with	NULL
21	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
displaying	NULL
an	NULL
MFI	NULL
of	NULL
54	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Instead	NULL
of	NULL
bt	NULL
,	NULL
cAMP	NULL
alone	NULL
,	NULL
PMA+	NULL
bt	NULL
,	NULL
cAMP	NULL
was	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
following	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
because	NULL
the	NULL
combination	NULL
is	NULL
a	NULL
more	NULL
potent	NULL
stimulus	NULL
for	NULL
IL-5	NULL
production	NULL
.	NULL

However	NULL
,	NULL
the	NULL
overall	NULL
effect	NULL
of	NULL
$	NULL
B203580	NULL
was	NULL
the	NULL
same	NULL
whether	NULL
bt	NULL
,	NULL
cAMP	NULL
or	NULL
PMA+	NULL
bt	NULL
,	NULL
cAMP	NULL
was	NULL
used	NULL
to	NULL
induce	NULL
IL-5	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
is	NULL
now	NULL
well	NULL
established	NULL
that	NULL
the	NULL
three	NULL
cytokines	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
,	NULL
play	NULL
critical	NULL
and	NULL
distinct	NULL
roles	NULL
in	NULL
asthma	NULL
pathogenesis	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
the	NULL
production	NULL
of	NULL
all	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
Th2	NULL
cells	NULL
obtained	NULL
by	NULL
differentiation	NULL
of	NULL
primary	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
DO11.10	NULL
mice	NULL
,	NULL
which	NULL
are	NULL
transgenic	NULL
for	NULL
the	NULL
TCR	NULL
recognizing	NULL
the	NULL
OVA	NULL
peptide	NULL
323-339	NULL
Seven	NULL
days	NULL
after	NULL
priming	NULL
with	NULL
Ag	NULL
and	NULL
APCs	NULL
,	NULL
the	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
bt	NULL
,	NULL
cAMP	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
and	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
later	NULL
for	NULL
analysis	NULL
of	NULL
cytokine	NULL
production	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
PMA+bt	NULL
,	NULL
cAMP	NULL
increased	NULL
IL-5	NULL
and	NULL
IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
production	NULL
in	NULL
effector	NULL
Th2	NULL
cells	NULL
(	NULL
DO11.10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
increase	NULL
in	NULL
cAMP-induced	NULL
IL-5	NULL
and	NULL
IL-13	NULL
production	NULL
was	NULL
suppressed	NULL
by	NULL
$	NULL
B203580	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

The	NULL
inhibitor	NULL
$	NULL
B203580	NULL
did	NULL
not	NULL
affect	NULL
basal	NULL
expression	NULL
of	NULL
any	NULL
of	NULL
the	NULL
cytokines	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

To	NULL
show	NULL
the	NULL
specific	NULL
effect	NULL
of	NULL
cAMP	NULL
on	NULL
IL-5	NULL
and	NULL
IL-13	NULL
expression	NULL
,	NULL
the	NULL
effector	NULL
Th2	NULL
cells	NULL
(	NULL
DO11.10	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
an	NULL
efficient	NULL
inducer	NULL
of	NULL
IL-4	NULL
gene	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
IL-4	NULL
production	NULL
was	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
calcium-induced	NULL
IL-4	NULL
production	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
that	NULL
cAMP	NULL
is	NULL
a	NULL
poor	NULL
inducer	NULL
of	NULL
IL-4	NULL
but	NULL
a	NULL
strong	NULL
inducer	NULL
of	NULL
IL-5	NULL
and	NULL
suggest	NULL
that	NULL
full	NULL
induction	NULL
of	NULL
IL-4	NULL
gene	NULL
expression	NULL
requires	NULL
more	NULL
than	NULL
p38	NULL
MAPK	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
also	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
cAMP	NULL
can	NULL
induce	NULL
IL-13	NULL
production	NULL
and	NULL
provide	NULL
evidence	NULL
that	NULL
p38	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
cAMP-induced	NULL
IL-5	NULL
and	NULL
IL-13	NULL
production	NULL
in	NULL
effector	NULL
Th2	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
GATA-3-dependent	NULL
promoter	NULL
activation	NULL
in	NULL
Th2	NULL
cells	NULL
To	NULL
further	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
p38	NULL
in	NULL
IL-4	NULL
and	NULL
IL-5	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
SB203580	NULL
to	NULL
inhibit	NULL
IL-4	NULL
and	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
the	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
SB203580	NULL
,	NULL
but	NULL
not	NULL
the	NULL
ERK	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
dose-dependent	NULL
decrease	NULL
in	NULL
IL-5	NULL
promoter	NULL
activity	NULL
with	NULL
a	NULL
50	NULL
%	NULL
decrease	NULL
at	NULL
the	NULL
highest	NULL
dose	NULL
of	NULL
the	NULL
inhibitor	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
no	NULL
inhibition	NULL
of	NULL
PMA	NULL
induced	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
SB203580	NULL
or	NULL
PD98059	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
cAMP-induced	NULL
p38	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
IL-5	NULL
promoter	NULL
activation	NULL
probably	NULL
through	NULL
phosphorylation	NULL
of	NULL
specific	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
activated	NULL
by	NULL
this	NULL
kinase	NULL
.	NULL

It	NULL
is	NULL
to	NULL
be	NULL
noted	NULL
that	NULL
multiple	NULL
isoforms	NULL
of	NULL
p38	NULL
kinase	NULL
,	NULL
a	NULL
,	NULL
B	NULL
,	NULL
y	NULL
,	NULL
and	NULL
8	NULL
have	NULL
been	NULL
described	NULL
and	NULL
the	NULL
p38	NULL
kinase	NULL
inhibitor	NULL
SB203580	NULL
can	NULL
only	NULL
inhibit	NULL
the	NULL
«	NULL
and	NULL
B	NULL
forms	NULL
of	NULL
p38	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
_	NULL
The	NULL
(	NULL
D10	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

Blockade	NULL
of	NULL
p38	NULL
activation	NULL
by	NULL
$	NULL
B203580	NULL
inhibits	NULL
IL-5	NULL
and	NULL
IL-13	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Analysis	NULL
of	NULL
IL-5	NULL
expression	NULL
in	NULL
D10	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
$	NULL
B203580	NULL
by	NULL
intracellular	NULL
cytokine	NULL
staining	NULL
.	NULL

D10	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
+	NULL
bt	NULL
,	NULL
cAMP	NULL
(	NULL
for	NULL
IL-5	NULL
expression	NULL
)	NULL
in	NULL
the	NULL
10°	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
Counts	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
10	NULL
)	NULL
FL2	NULL
1.81	NULL
%	NULL
10	NULL
``	NULL
10	NULL
Height	NULL
5601	NULL
PMA+bt	NULL
;	NULL
cAMP	NULL
$	NULL
B203580	NULL
21.02	NULL
%	NULL
I	NULL
M1	NULL
PMA+bt	NULL
;	NULL
cAMP	NULL
64.08	NULL
%	NULL
M1	NULL
M1	NULL
Counts	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
Counts	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
10	NULL
``	NULL
=	NULL
ao	NULL
``	NULL
qo	NULL
``	NULL
40	NULL
%	NULL
aot	NULL
40	NULL
``	NULL
_	NULL
ao	NULL
``	NULL
qo	NULL
``	NULL
402	NULL
40°	NULL
ao	NULL
``	NULL
FL2-Height	NULL
FL2-Height	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
brefeldin	NULL
A	NULL
to	NULL
block	NULL
cytokine	NULL
secretion	NULL
.	NULL

PE-anti-IL-5	NULL
Ab	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Compa-	NULL
rable	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
indepen-	NULL
B	NULL
dent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Analysis	NULL
of	NULL
cytokine	NULL
expression	NULL
in	NULL
bt	NULL
,	NULL
cAMP-stimulated	NULL
Th2	NULL
cells	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
DO11.10	NULL
mice	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

Splenic	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
20	NULL
DO11.10	NULL
mice	NULL
and	NULL
stimulated	NULL
with	NULL
the	NULL
an-tigenic	NULL
peptide	NULL
pOVA*	NULL
``	NULL
*	NULL
>	NULL
°	NULL
and	NULL
syngeneic	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
under	NULL
Th2-differentiat-ing	NULL
conditions	NULL
.	NULL

After	NULL
7	NULL
days	NULL
,	NULL
the	NULL
primed	NULL
CD4	NULL
*	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
PMA+bt	NULL
,	NULL
cAMP	NULL
with	NULL
or	NULL
without	NULL
$	NULL
B203580	NULL
(	NULL
1	NULL
and	NULL
10	NULL
uM	NULL
)	NULL
or	NULL
PMA-+ionomycin	NULL
with	NULL
or	NULL
without	NULL
$	NULL
B203580	NULL
(	NULL
10	NULL
M	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
Culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
expression	NULL
by	NULL
ELISA	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
.	NULL

60	NULL
40	NULL
pg/ml	NULL
0	NULL
PMA+btcAMP	NULL
$	NULL
B203580	NULL
-	NULL
_	NULL
8000	NULL
E	NULL
60007	NULL
%	NULL
2	NULL
4000	NULL
2000	NULL
o-PMA+ionomycin	NULL
$	NULL
B203580	NULL
Recently	NULL
,	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
shown	NULL
to	NULL
preferentially	NULL
express	NULL
p38	NULL
and	NULL
p388	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
SB203580	NULL
to	NULL
completely	NULL
inhibit	NULL
IL-5	NULL
promoter	NULL
activity	NULL
may	NULL
be	NULL
due	NULL
to	NULL
residual	NULL
cAMP-stimulated	NULL
phospho-p388	NULL
activity	NULL
in	NULL
D1O	NULL
cells	NULL
.	NULL

The	NULL
selective	NULL
inhibition	NULL
of	NULL
IL-5	NULL
promoter	NULL
activity	NULL
by	NULL
$	NULL
B203580	NULL
together	NULL
with	NULL
our	NULL
previous	NULL
studies	NULL
demonstrating	NULL
a	NULL
direct	NULL
activation	NULL
of	NULL
the	NULL
IL-5	NULL
but	NULL
not	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
GATA-3	NULL
(	NULL
48	NULL
)	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
GATA-3	NULL
was	NULL
the	NULL
downstream	NULL
substrate	NULL
of	NULL
the	NULL
p38	NULL
signaling	NULL
pathway	NULL
activated	NULL
by	NULL
cAMP	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
a	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
-luciferase	NULL
gene	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
D10	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
-directed	NULL
luciferase	NULL
activity	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
stimulation	NULL
with	NULL
PMA+bt	NULL
,	NULL
cAMP	NULL
(	NULL
or	NULL
bt	NULL
,	NULL
cAMP	NULL
alone	NULL
)	NULL
but	NULL
not	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
activation	NULL
was	NULL
mediated	NULL
by	NULL
a	NULL
specific	NULL
selective	NULL
pathway	NULL
induced	NULL
by	NULL
cAMP	NULL
.	NULL

Similar	NULL
to	NULL
its	NULL
effects	NULL
on	NULL
the	NULL
IL-5	NULL
promoter	NULL
,	NULL
$	NULL
B203580	NULL
caused	NULL
a	NULL
dose-dependent	NULL
decrease	NULL
in	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
-luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
earlier	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
p38	NULL
inhibitor	NULL
to	NULL
fully	NULL
repress	NULL
reporter	NULL
gene	NULL
activation	NULL
is	NULL
probably	NULL
because	NULL
of	NULL
residual	NULL
activities	NULL
of	NULL
other	NULL
p38	NULL
isoforms	NULL
such	NULL
as	NULL
p388	NULL
in	NULL
the	NULL
cells	NULL
that	NULL
may	NULL
also	NULL
be	NULL
activated	NULL
by	NULL
cAMP	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
ERK	NULL
inhibitor	NULL
PD98059	NULL
did	NULL
not	NULL
affect	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
-luciferase	NULL
activity	NULL
.	NULL

Phosphorylation	NULL
of	NULL
GATA-3	NULL
by	NULL
activated	NULL
p38	NULL
Inhibition	NULL
of	NULL
GATA-3-dependent	NULL
promoter	NULL
activity	NULL
by	NULL
the	NULL
p38	NULL
kinase	NULL
inhibitor	NULL
indicated	NULL
that	NULL
p38	NULL
kinase	NULL
may	NULL
contribute	NULL
to	NULL
GATA-3	NULL
activation	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
.	NULL

Because	NULL
there	NULL
was	NULL
no	NULL
report	NULL
on	NULL
posttranslational	NULL
modifications	NULL
of	NULL
GATA-3	NULL
,	NULL
we	NULL
first	NULL
investigated	NULL
whether	NULL
GATA-3	NULL
could	NULL
be	NULL
phosphorylated	NULL
after	NULL
cAMP	NULL
stimulation	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

D10	NULL
cells	NULL
were	NULL
metabolically	NULL
labeled	NULL
with	NULL
IL-4	NULL
+o	NULL
+	NULL
+	NULL
-	NULL
+	NULL
saz	NULL
]	NULL
IL-5	NULL
PE	NULL
*	NULL
Th2	NULL
Cells	NULL
:	NULL
DO11.10	NULL
TCR	NULL
Tg	NULL
(	NULL
Ova	NULL
)	NULL
Mice	NULL
IL-5	NULL
IL-13	NULL
1000	NULL
soo	NULL
{	NULL
€	NULL
soo	NULL
{	NULL
2	NULL
4001	NULL
200-	NULL
4000	NULL
7	NULL
_	NULL
3000	NULL
&	NULL
5	NULL
2000	NULL
a	NULL
.	NULL

1000	NULL
IL-4	NULL
++	NULL
inorganic	NULL
°°P	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cAMP	NULL
,	NULL
and	NULL
GATA-3	NULL
protein	NULL
was	NULL
recovered	NULL
by	NULL
immunoprecipitation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
a	NULL
phosphorylated	NULL
protein	NULL
of	NULL
expected	NULL
molecular	NULL
size	NULL
(	NULL
55	NULL
kDa	NULL
)	NULL
was	NULL
obtained	NULL
using	NULL
anti-GATA-3	NULL
but	NULL
not	NULL
control	NULL
Ab	NULL
.	NULL

Although	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
GATA-3	NULL
phosphorylation	NULL
was	NULL
observed	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
cAMP	NULL
augmented	NULL
the	NULL
level	NULL
of	NULL
phosphorylation	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
GATA-3	NULL
exists	NULL
as	NULL
a	NULL
phosphoprotein	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
and	NULL
cAMP	NULL
signaling	NULL
is	NULL
able	NULL
to	NULL
increase	NULL
GATA-3	NULL
phosphorylation	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
p38	NULL
MAPK	NULL
can	NULL
directly	NULL
phosphorylate	NULL
GATA-3	NULL
,	NULL
recombinant	NULL
His-tagged	NULL
GATA-3	NULL
was	NULL
used	NULL
as	NULL
a	NULL
substrate	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
using	NULL
an	NULL
active	NULL
form	NULL
of	NULL
recombinant	NULL
p38	NULL
kinase	NULL
.	NULL

Recombinant	NULL
ATF-2	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
in	NULL
these	NULL
assays	NULL
.	NULL

Because	NULL
insect	NULL
cells	NULL
have	NULL
high	NULL
levels	NULL
of	NULL
His-rich	NULL
proteins	NULL
,	NULL
the	NULL
recombinant	NULL
GATA-3	NULL
protein	NULL
preparation	NULL
had	NULL
low	NULL
levels	NULL
of	NULL
contaminant	NULL
proteins	NULL
.	NULL

Therefore	NULL
,	NULL
GATA-3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
anti-GATA-3	NULL
Ab	NULL
after	NULL
termination	NULL
of	NULL
the	NULL
kinase	NULL
reaction	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
phosphorylation	NULL
of	NULL
GATA-3	NULL
and	NULL
ATF-2	NULL
occurred	NULL
in	NULL
a	NULL
p38	NULL
kinase-dependent	NULL
fashion	NULL
;	NULL
no	NULL
phosphorylation	NULL
of	NULL
either	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
.	NULL

Also	NULL
,	NULL
no	NULL
phosphorylated	NULL
band	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
added	NULL
substrate	NULL
.	NULL

Discussion	NULL
Several	NULL
studies	NULL
published	NULL
to	NULL
date	NULL
have	NULL
shown	NULL
that	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
cAMP	NULL
induces	NULL
Th2	NULL
cytokine	NULL
production	NULL
but	NULL
decreases	NULL
Th1	NULL
cytokine	NULL
production	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
increased	NULL
production	NULL
of	NULL
Th2	NULL
cytokines	NULL
in	NULL
response	NULL
to	NULL
cAMP	NULL
.	NULL

Our	NULL
studies	NULL
summarized	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
highlight	NULL
the	NULL
following	NULL
points	NULL
:	NULL
1	NULL
)	NULL
cAMP	NULL
activates	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5602	NULL
J	NULL
>	NULL
wt.IL-5	NULL
(	NULL
-1700/+24	NULL
)	NULL
cAMP	NULL
ACTIVATES	NULL
P38	NULL
MAPK	NULL
IN	NULL
TH2	NULL
CELLS	NULL
wt.IL-4	NULL
(	NULL
-741/+60	NULL
)	NULL
120	NULL
FIGURE	NULL
4	NULL
.	NULL

Inhibition	NULL
of	NULL
GATA-3-	NULL
80	NULL
dependent	NULL
promoter	NULL
activities	NULL
in	NULL
D10	NULL
cells	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

D10	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
10	NULL
pug	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
RSV-B-ga-lactosidase	NULL
(	NULL
CMV-B-gal	NULL
)	NULL
plasmid	NULL
,	NULL
and	NULL
carrier	NULL
plasmid	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimu-	NULL
60	NULL
40	NULL
20	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
lated	NULL
or	NULL
stimulated	NULL
with	NULL
PMA-+bt	NULL
;	NULL
cAMP	NULL
__	NULL
az	NULL
]	NULL
_-	NULL
]	NULL
$	NULL
B203580	NULL
(	NULL
P+C	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
P+1	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
1	NULL
and	NULL
10	NULL
M	NULL
)	NULL
or	NULL
PD98059	NULL
(	NULL
10	NULL
and	NULL
50	NULL
uM	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
20	NULL
h	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
LUC	NULL
180	NULL
P+l	NULL
160	NULL
140	NULL
120	NULL
100	NULL
80	NULL
60	NULL
40	NULL
20	NULL
PAC	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
_A	NULL
$	NULL
B203580	NULL
A	NULL
PD98059	NULL
PD98059	NULL
(	NULL
GATA	NULL
)	NULL
3	NULL
-LUC	NULL
activity	NULL
.	NULL

The	NULL
average	NULL
absolute	NULL
100	NULL
%	NULL
lucif-	NULL
10000	NULL
erase	NULL
activities	NULL
when	NULL
the	NULL
IL-5	NULL
and	NULL
the	NULL
IL-4	NULL
9000	NULL
promoters	NULL
were	NULL
stimulated	NULL
with	NULL
P+C	NULL
or	NULL
8000	NULL
P+I	NULL
were	NULL
13,820	NULL
and	NULL
22,200	NULL
relative	NULL
light	NULL
7000	NULL
units	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
were	NULL
normal-	NULL
6000	NULL
ized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Shown	NULL
is	NULL
5000	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
with	NULL
4000	NULL
<	NULL
5	NULL
%	NULL
deviation	NULL
between	NULL
experiments	NULL
.	NULL

3000	NULL
2000	NULL
1000	NULL
Luciferase	NULL
Activity	NULL
p38	NULL
MAPK	NULL
in	NULL
a	NULL
dominant	NULL
fashion	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
Th1	NULL
cells	NULL
;	NULL
and	NULL
2	NULL
)	NULL
GATA-3	NULL
is	NULL
a	NULL
substrate	NULL
of	NULL
p38	NULL
kinase	NULL
,	NULL
which	NULL
explains	NULL
,	NULL
at	NULL
least	NULL
partly	NULL
,	NULL
the	NULL
distinct	NULL
effect	NULL
of	NULL
cAMP	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

The	NULL
PKA	NULL
pathway	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
cAMP-induced	NULL
responses	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
.	NULL

Several	NULL
isozymes	NULL
of	NULL
PKA	NULL
have	NULL
been	NULL
described	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
type	NULL
I	NULL
isozyme	NULL
is	NULL
the	NULL
major	NULL
form	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
regulatory	NULL
subunit	NULL
of	NULL
PKA	NULL
,	NULL
which	NULL
is	NULL
the	NULL
intracellular	NULL
receptor	NULL
for	NULL
cAMP	NULL
,	NULL
is	NULL
deficient	NULL
in	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
patients	NULL
with	NULL
systemic	NULL
lupus	NULL
er-ythematosus	NULL
(	NULL
51	NULL
)	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
PKA	NULL
involvement	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
our	NULL
studies	NULL
,	NULL
is	NULL
due	NULL
to	NULL
a	NULL
down-modulation	NULL
of	NULL
PKA-I	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Alterna-tively	NULL
,	NULL
the	NULL
PKA	NULL
and	NULL
the	NULL
p38	NULL
MAPK	NULL
pathways	NULL
may	NULL
be	NULL
antagonistic	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
balance	NULL
of	NULL
these	NULL
pathways	NULL
may	NULL
be	NULL
different	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
although	NULL
the	NULL
PKA	NULL
pathway	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
cAMP-induced	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
it	NULL
appears	NULL
to	NULL
regulate	NULL
cAMP	NULL
-induced	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
the	NULL
thymoma	NULL
line	NULL
EL-4	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
PKA	NULL
was	NULL
shown	NULL
to	NULL
efficiently	NULL
activate	NULL
the	NULL
IL-5	NULL
promoter	NULL
in	NULL
EL-4	NULL
cells	NULL
in	NULL
a	NULL
PKA-dependent	NULL
fashion	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
EL-4	NULL
cells	NULL
,	NULL
the	NULL
PKA	NULL
pathway	NULL
and	NULL
,	NULL
most	NULL
likely	NULL
,	NULL
the	NULL
phorbol	NULL
ester-induced	NULL
PKC	NULL
pathway	NULL
synergistically	NULL
activate	NULL
the	NULL
IL-5	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
untransformed	NULL
Th2	NULL
cells	NULL
,	NULL
cAMP	NULL
alone	NULL
can	NULL
induce	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
PKA-independent	NULL
fashion	NULL
via	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
.	NULL

In	NULL
Th1	NULL
cells	NULL
,	NULL
the	NULL
low	NULL
level	NULL
of	NULL
cAMP-induced	NULL
p38	NULL
phosphorylation	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
PKA	NULL
inhibitor	NULL
H89	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
1	NULL
)	NULL
the	NULL
weak	NULL
p38	NULL
phosphorylation	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
directly	NULL
mediated	NULL
by	NULL
PKA	NULL
or	NULL
due	NULL
to	NULL
cross-talk	NULL
with	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
;	NULL
and	NULL
2	NULL
)	NULL
the	NULL
PKA	NULL
pathway	NULL
is	NULL
antagonistic	NULL
to	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
.	NULL

ro	NULL
o	NULL
=	NULL
o	NULL
80	NULL
eo	NULL
40	NULL
20	NULL
Véz	NULL
_41	NULL
o	NULL
a/	NULL
$	NULL
B203580	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
u-	NULL
]	NULL
PD98059	NULL
A	NULL
novel	NULL
finding	NULL
in	NULL
our	NULL
studies	NULL
is	NULL
the	NULL
differential	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
Th2	NULL
and	NULL
Th1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
cAMP	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

p38	NULL
MAPK	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
major	NULL
tyrosine-phosphorylated	NULL
protein	NULL
of	NULL
38	NULL
kDa	NULL
when	NULL
murine	NULL
macrophage	NULL
cell	NULL
lines	NULL
were	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
four	NULL
mammalian	NULL
isoforms	NULL
have	NULL
been	NULL
de-scribed	NULL
:	NULL
p38	NULL
,	NULL
p38B	NULL
,	NULL
p38y	NULL
,	NULL
and	NULL
p388	NULL
(	NULL
26	NULL
,	NULL
31	NULL
,	NULL
41	NULL
,	NULL
52-60	NULL
)	NULL
.	NULL

Although	NULL
p38	NULL
MAPK	NULL
was	NULL
first	NULL
implicated	NULL
in	NULL
the	NULL
production	NULL
of	NULL
proin-flammation	NULL
cytokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
TNF-a	NULL
and	NULL
IL-1B	NULL
)	NULL
by	NULL
monocytes/	NULL
macrophages	NULL
(	NULL
31	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
kinase	NULL
has	NULL
also	NULL
been	NULL
described	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
systems	NULL
.	NULL

An	NULL
interesting	NULL
finding	NULL
in	NULL
these	NULL
studies	NULL
is	NULL
that	NULL
p38	NULL
is	NULL
an	NULL
important	NULL
integrator	NULL
of	NULL
TCR/CD28	NULL
stimulation	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
primary	NULL
naive	NULL
mouse	NULL
CD4	NULL
~	NULL
T	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
stimulation	NULL
of	NULL
naive	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
TCR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
costimulation	NULL
was	NULL
shown	NULL
to	NULL
activate	NULL
this	NULL
signaling	NULL
pathway	NULL
,	NULL
and	NULL
its	NULL
blockade	NULL
by	NULL
SB203580	NULL
reduced	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
effector	NULL
cells	NULL
,	NULL
although	NULL
activation	NULL
of	NULL
p38	NULL
kinase	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
requirement	NULL
for	NULL
Th1	NULL
(	NULL
IFN-y	NULL
)	NULL
but	NULL
not	NULL
Th2	NULL
cytokine	NULL
production	NULL
in	NULL
response	NULL
to	NULL
TCR/	NULL
CD28	NULL
stimulation	NULL
in	NULL
murine	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
,	NULL
studies	NULL
of	NULL
human	NULL
Th2	NULL
effector	NULL
cells	NULL
show	NULL
a	NULL
requirement	NULL
for	NULL
this	NULL
kinase	NULL
in	NULL
IL-4	NULL
production	NULL
in	NULL
response	NULL
to	NULL
TCR/CD28	NULL
costimulation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
dependence	NULL
of	NULL
IL-4	NULL
on	NULL
CD28	NULL
costimulation	NULL
in	NULL
human	NULL
but	NULL
not	NULL
murine	NULL
effector	NULL
Th2	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
p38	NULL
kinase	NULL
in	NULL
cAMP-induced	NULL
effects	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

The	NULL
p38	NULL
inhibitor	NULL
SB203580	NULL
blocks	NULL
the	NULL
activity	NULL
of	NULL
p38	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
ATP-binding	NULL
site	NULL
on	NULL
p38	NULL
MAPK	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
inhibitor	NULL
is	NULL
specific	NULL
for	NULL
p38a	NULL
@	NULL
and	NULL
p38	NULL
and	NULL
does	NULL
not	NULL
inhibit	NULL
p38y	NULL
and	NULL
p388	NULL
(	NULL
55	NULL
,	NULL
56	NULL
,	NULL
60-62	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
showed	NULL
that	NULL
both	NULL
p38	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
IP	NULL
:	NULL
Control	NULL
Ig	NULL
_	NULL
anti-GATA-3	NULL
F	NULL
--	NULL
-bt	NULL
;	NULL
cAMP	NULL
-	NULL
+	NULL
ame	NULL
.	NULL

<	NULL
+	NULL
B	NULL
rGATA-3	NULL
_	NULL
rATF-2	NULL
p38	NULL
-	NULL
+	NULL
-	NULL
+	NULL
+	NULL
cein	NULL
cae	NULL
FIGURE	NULL
5.	NULL
cAMP	NULL
stimulates	NULL
GATA-3	NULL
phosphorylation	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Phosphorylation	NULL
of	NULL
GATA-3	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

D10	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
®®PJorthophosphate	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
bt	NULL
,	NULL
cAMP	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
GATA-3	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
agarose-conjugated	NULL
anti-GATA-3	NULL
mAb	NULL
or	NULL
control	NULL
Ig	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

B	NULL
,	NULL
GATA-3	NULL
is	NULL
phosphorylated	NULL
by	NULL
p38	NULL
in	NULL
vitro	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
recombinant	NULL
GATA-3	NULL
protein	NULL
produced	NULL
in	NULL
insect	NULL
cells	NULL
(	NULL
Sf9	NULL
)	NULL
or	NULL
recombinant	NULL
ATF-2	NULL
was	NULL
incubated	NULL
with	NULL
an	NULL
active	NULL
form	NULL
of	NULL
p38	NULL
kinase	NULL
(	NULL
Stratagene	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

GATA-3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
anti-GATA-3	NULL
Ab	NULL
.	NULL

The	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
using	NULL
a	NULL
phosphorimager	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
p3868	NULL
isoforms	NULL
are	NULL
highly	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
SB203580	NULL
to	NULL
completely	NULL
inhibit	NULL
reporter	NULL
gene	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
D10	NULL
cells	NULL
express	NULL
both	NULL
iso-forms	NULL
,	NULL
and	NULL
both	NULL
may	NULL
contribute	NULL
toward	NULL
activation	NULL
of	NULL
GATA-3	NULL
.	NULL

However	NULL
,	NULL
the	NULL
complete	NULL
inhibition	NULL
of	NULL
IL-5	NULL
and	NULL
IL-13	NULL
production	NULL
by	NULL
$	NULL
B203580	NULL
in	NULL
in	NULL
vitro	NULL
differentiated	NULL
Th2	NULL
cells	NULL
suggests	NULL
that	NULL
the	NULL
major	NULL
form	NULL
of	NULL
p38	NULL
in	NULL
Th2	NULL
cells	NULL
is	NULL
p38a	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
and	NULL
others	NULL
demonstrated	NULL
Th2-specific	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
(	NULL
43	NULL
,	NULL
63	NULL
,	NULL
64	NULL
)	NULL
and	NULL
showed	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
IL-5	NULL
gene	NULL
PGE	NULL
,	NULL
IL-10	NULL
,	NULL
Cholera	NULL
Toxin	NULL
,	NULL
Forskolin	NULL
,	NULL
bt	NULL
,	NULL
cAMP	NULL
Thi	NULL
Th2	NULL
cAMP	NULL
4	NULL
cAMP	NULL
¢	NULL
/	NULL
Dominant	NULL
PKA	NULL
?	NULL

PKA	NULL
x	NULL
19	NULL
Fik	NULL
MKK3/6	NULL
¥	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
l	NULL
p38D	NULL
GATA3-B	NULL
IL-5/L-13	NULL
4	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
cAMP	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Elevation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
elicited	NULL
by	NULL
different	NULL
agents	NULL
inhibits	NULL
cytokine	NULL
production	NULL
in	NULL
Th1	NULL
cells	NULL
but	NULL
stimulates	NULL
IL-5	NULL
and	NULL
IL-13	NULL
production	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

cAMP-induced	NULL
cytokine	NULL
production	NULL
in	NULL
Th2	NULL
cells	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
PKA	NULL
pathway	NULL
but	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
.	NULL

X	NULL
denotes	NULL
a	NULL
presently	NULL
uncharacterized	NULL
signaling	NULL
interme-diate	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Th2	NULL
cells	NULL
,	NULL
p38	NULL
kinase	NULL
phosphorylation	NULL
is	NULL
barely	NULL
augmented	NULL
by	NULL
cAMP	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Our	NULL
study	NULL
shows	NULL
that	NULL
p38	NULL
kinase	NULL
can	NULL
phosphorylate	NULL
the	NULL
Th2-specific	NULL
factor	NULL
GATA-3	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
cAMP	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

5603	NULL
expression	NULL
(	NULL
19	NULL
,	NULL
43	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
GATA-3	NULL
directly	NULL
activates	NULL
the	NULL
IL-5	NULL
but	NULL
not	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
48	NULL
,	NULL
65	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
GATA-3	NULL
is	NULL
also	NULL
important	NULL
for	NULL
IL-4	NULL
and	NULL
IL-13	NULL
gene	NULL
expression	NULL
as	NULL
we	NULL
have	NULL
recently	NULL
demonstrated	NULL
using	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
GATA-3	NULL
(	NULL
44	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
GATA-3-induced	NULL
IL-4	NULL
and	NULL
IL-13	NULL
gene	NULL
expression	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
c-Maf	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
IL-4	NULL
gene	NULL
expression	NULL
and	NULL
directly	NULL
activates	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
66	NULL
,	NULL
67	NULL
)	NULL
.	NULL

However	NULL
,	NULL
c-Maf	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
directly	NULL
regulate	NULL
IL-5	NULL
or	NULL
IL-13	NULL
gene	NULL
expression	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
differential	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
the	NULL
IL-5/IL-13	NULL
genes	NULL
to	NULL
cAMP	NULL
in	NULL
effector	NULL
Th2	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
cAMP	NULL
to	NULL
activate	NULL
c-Maf	NULL
.	NULL

Also	NULL
,	NULL
although	NULL
cAMP-induced	NULL
p38	NULL
MAPK	NULL
activation	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
cause	NULL
IL-4	NULL
gene	NULL
expression	NULL
,	NULL
calcium-induced	NULL
IL-4	NULL
production	NULL
involves	NULL
p38	NULL
MAPK	NULL
.	NULL

Six	NULL
members	NULL
of	NULL
GATA	NULL
family	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exist	NULL
as	NULL
phosphoproteins	NULL
(	NULL
68	NULL
,	NULL
69	NULL
)	NULL
.	NULL

By	NULL
phosphorylation	NULL
mapping	NULL
,	NULL
GATA-1	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
on	NULL
six	NULL
serine	NULL
residues	NULL
in	NULL
uninduced	NULL
cells	NULL
and	NULL
,	NULL
after	NULL
stimulation	NULL
,	NULL
a	NULL
seventh	NULL
serine	NULL
residue	NULL
became	NULL
phosphorylated	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
GATA-2	NULL
was	NULL
increased	NULL
after	NULL
IL-3	NULL
stimulation	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
GATA-3	NULL
also	NULL
exists	NULL
as	NULL
a	NULL
phosphoprotein	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
cAMP	NULL
can	NULL
induce	NULL
GATA-3	NULL
phosphorylation	NULL
via	NULL
p38	NULL
MAPK	NULL
and	NULL
stimulate	NULL
GATA-3-dependent	NULL
promoter	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
phosphorylation	NULL
will	NULL
affect	NULL
the	NULL
DNA-binding	NULL
ability	NULL
of	NULL
GATA-3	NULL
because	NULL
the	NULL
GATA-3	NULL
protein	NULL
recovered	NULL
from	NULL
unstimulated	NULL
Th2	NULL
cells	NULL
or	NULL
in	NULL
vitro	NULL
translated	NULL
GATA-3	NULL
are	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
IL-5	NULL
GATA	NULL
doublet	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL

The	NULL
p38	NULL
kinase-induced	NULL
phosphorylation	NULL
of	NULL
GATA-3	NULL
may	NULL
be	NULL
important	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
regulatory	NULL
factors	NULL
to	NULL
promote	NULL
IL-5	NULL
gene	NULL
expression	NULL
or	NULL
to	NULL
make	NULL
the	NULL
IL-4/IL-13	NULL
locus	NULL
more	NULL
accessible	NULL
to	NULL
other	NULL
factors	NULL
.	NULL

The	NULL
optimum	NULL
consensus	NULL
sequence	NULL
for	NULL
MAPK	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
PPTP	NULL
,	NULL
and	NULL
one	NULL
such	NULL
motif	NULL
exists	NULL
in	NULL
the	NULL
GATA-3	NULL
coding	NULL
region	NULL
.	NULL

The	NULL
retention	NULL
of	NULL
wild-type	NULL
activity	NULL
by	NULL
the	NULL
GATA-3	NULL
mutant	NULL
T155A	NULL
suggests	NULL
that	NULL
this	NULL
site	NULL
may	NULL
not	NULL
be	NULL
the	NULL
correct	NULL
site	NULL
for	NULL
the	NULL
response	NULL
to	NULL
cAMP	NULL
(	NULL
J.	NULL
M.	NULL
LaPorte	NULL
and	NULL
C.-H.	NULL
Chen	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
12	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
(	NULL
(	NULL
S/D	NULL
)	NULL
P	NULL
)	NULL
for	NULL
MAPK	NULL
on	NULL
GATA-3	NULL
,	NULL
and	NULL
which	NULL
of	NULL
these	NULL
sequences	NULL
is	NULL
important	NULL
for	NULL
phosphorylation	NULL
by	NULL
p38	NULL
kinase	NULL
is	NULL
currently	NULL
under	NULL
investigation	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
p38	NULL
MAPK	NULL
phosphorylates	NULL
an	NULL
unconventional	NULL
site	NULL
in	NULL
GATA-3	NULL
.	NULL

The	NULL
signaling	NULL
intermediate	NULL
that	NULL
couples	NULL
intracellular	NULL
cAMP	NULL
to	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
in	NULL
Th2	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
P.	NULL
Ray	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Mary	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Aussel	NULL
,	NULL
B.	NULL
Ferrua	NULL
,	NULL
and	NULL
M.	NULL
Fehlmann	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin	NULL
2	NULL
synthesis	NULL
by	NULL
cAMP	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:1179	NULL
.	NULL

2	NULL
.	NULL

Lerner	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Jacobson	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Miller	NULL
.	NULL

1988	NULL
.	NULL

Cyclic	NULL
AMP	NULL
concentrations	NULL
modulate	NULL
both	NULL
calcium	NULL
flux	NULL
and	NULL
hydrolysis	NULL
of	NULL
phosphatidylinositol	NULL
phosphates	NULL
in	NULL
mouse	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:936	NULL
.	NULL

3	NULL
.	NULL

Kammer	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
C.	NULL
A.	NULL
Bochm	NULL
,	NULL
S.	NULL
A.	NULL
Rudolph	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Schultz	NULL
.	NULL

1988	NULL
.	NULL

Mobility	NULL
of	NULL
the	NULL
human	NULL
T	NULL
lymphocyte	NULL
surface	NULL
molecules	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
:	NULL
regulation	NULL
by	NULL
a	NULL
cAMP-dependent	NULL
pathway	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:792	NULL
.	NULL

4	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
2	NULL
transcription	NULL
factors	NULL
as	NULL
molecular	NULL
targets	NULL
of	NULL
cAMP	NULL
inhibition	NULL
:	NULL
delayed	NULL
inhibition	NULL
kinetics	NULL
and	NULL
combina-torial	NULL
transcription	NULL
roles	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:931	NULL
.	NULL

5	NULL
.	NULL

Betz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Fox	NULL
.	NULL

1991	NULL
.	NULL

Prostaglandin	NULL
E	NULL
;	NULL
inhibits	NULL
production	NULL
of	NULL
Th1	NULL
lymphokines	NULL
but	NULL
not	NULL
of	NULL
Th2	NULL
lymphokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:108	NULL
.	NULL

6	NULL
.	NULL

Anastassiou	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
F.	NULL
Paliogianni	NULL
,	NULL
J.	NULL
P.	NULL
Balow	NULL
,	NULL
H.	NULL
Yamada	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Boumpas	NULL
.	NULL

1992	NULL
.	NULL

Prostaglandin	NULL
E	NULL
,	NULL
and	NULL
other	NULL
cyclic	NULL
AMP-elevating	NULL
agents	NULL
modulate	NULL
IL-2	NULL
and	NULL
IL-2R	NULL
a	NULL
gene	NULL
expression	NULL
at	NULL
multiple	NULL
levels	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2845	NULL
.	NULL

7	NULL
.	NULL

Gajewski	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
S.	NULL
R.	NULL
Schell	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Fitch	NULL
.	NULL

1990	NULL
.	NULL

Evidence	NULL
implicating	NULL
utilization	NULL
of	NULL
different	NULL
T	NULL
cell	NULL
receptor-associated	NULL
signaling	NULL
pathways	NULL
by	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:4110	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5604	NULL
8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Zubiaga	NULL
,	NULL
M.	NULL
Merrow	NULL
,	NULL
N.	NULL
P.	NULL
Sauter	NULL
,	NULL
and	NULL
B.	NULL
T.	NULL
Huber	NULL
.	NULL

1990	NULL
.	NULL

Cholera	NULL
toxin	NULL
discriminates	NULL
between	NULL
T	NULL
helper	NULL
1	NULL
and	NULL
2	NULL
cells	NULL
in	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
activation	NULL
:	NULL
role	NULL
of	NULL
cAMP	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:95.	NULL
.	NULL

Van	NULL
der	NULL
Pouw-Kraan	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
L.	NULL
C.	NULL
Bocije	NULL
,	NULL
R.	NULL
J.	NULL
Smeenk	NULL
,	NULL
J.	NULL
Wijdenes	NULL
,	NULL
and	NULL
L.	NULL
Aarden	NULL
.	NULL

1995	NULL
.	NULL

Prostaglandin	NULL
E	NULL
;	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
human	NULL
interleukin	NULL
12	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:775	NULL
.	NULL

Kopf	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Brombacher	NULL
,	NULL
P.	NULL
D.	NULL
Hodgkin	NULL
,	NULL
A.	NULL
J.	NULL
Ramsay	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Milbourne	NULL
,	NULL
W.	NULL
J.	NULL
Dai	NULL
,	NULL
K.	NULL
S.	NULL
Ovington	NULL
,	NULL
C.	NULL
A.	NULL
Behm	NULL
,	NULL
G.	NULL
Kohler	NULL
,	NULL
I.	NULL
G.	NULL
Young	NULL
,	NULL
and	NULL
K.	NULL
I.	NULL
Matthaci	NULL
.	NULL

1996	NULL
.	NULL

IL-5-deficient	NULL
mice	NULL
have	NULL
a	NULL
developmental	NULL
defect	NULL
in	NULL
CDS*	NULL
B-1	NULL
cells	NULL
and	NULL
lack	NULL
eosinophilia	NULL
but	NULL
have	NULL
normal	NULL
antibody	NULL
and	NULL
cytotoxic	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Immunity	NULL
4:15	NULL
.	NULL

Foster	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
S.	NULL
P.	NULL
Hogan	NULL
,	NULL
A.	NULL
J.	NULL
Ramsay	NULL
,	NULL
K.	NULL
I.	NULL
Matthaci	NULL
,	NULL
and	NULL
I.	NULL
G.	NULL
Young	NULL
.	NULL

1996	NULL
.	NULL

Interleukin	NULL
5	NULL
deficiency	NULL
abolishes	NULL
eosinophilia	NULL
,	NULL
airways	NULL
hyperreactivity	NULL
,	NULL
and	NULL
lung	NULL
damage	NULL
in	NULL
a	NULL
mouse	NULL
asthma	NULL
model	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:195	NULL
.	NULL

Dent	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
M.	NULL
Strath	NULL
,	NULL
A.	NULL
L.	NULL
Mellor	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Sanderson	NULL
.	NULL

1990	NULL
.	NULL

Eosinophilia	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
interleukin	NULL
5	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:1425	NULL
.	NULL

Corry	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
H.	NULL
G.	NULL
Folkesson	NULL
,	NULL
M.	NULL
L.	NULL
Warnock	NULL
,	NULL
D.	NULL
J.	NULL
Erle	NULL
,	NULL
M.	NULL
A.	NULL
Matthay	NULL
,	NULL
J.	NULL
P.	NULL
Wiener-Kronish	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Locksley	NULL
.	NULL

1996	NULL
.	NULL

Interleukin	NULL
4	NULL
,	NULL
but	NULL
not	NULL
interleukin	NULL
5	NULL
or	NULL
eosinophils	NULL
,	NULL
is	NULL
required	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
acute	NULL
airway	NULL
hyperreactivity	NULL
.	NULL

[	NULL
Published	NULL
erratum	NULL
appears	NULL
in	NULL
1997	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1715	NULL
.	NULL
]	NULL

.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
:	NULL
109	NULL
.	NULL

Cohn	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
J.	NULL
Homer	NULL
,	NULL
H.	NULL
MacLeod	NULL
,	NULL
M.	NULL
Mohrs	NULL
,	NULL
F.	NULL
Brombacher	NULL
,	NULL
and	NULL
K.	NULL
Bottomly	NULL
.	NULL

1999	NULL
.	NULL

Th2-induced	NULL
airway	NULL
mucus	NULL
production	NULL
is	NULL
dependent	NULL
on	NULL
IL-4R	NULL
@	NULL
,	NULL
but	NULL
not	NULL
on	NULL
eosinophils	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:6178	NULL
.	NULL

Naora	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
I.	NULL
G.	NULL
Young	NULL
.	NULL

1994	NULL
.	NULL

Mechanisms	NULL
regulating	NULL
the	NULL
mRNA	NULL
levels	NULL
of	NULL
interleukin-5	NULL
and	NULL
two	NULL
other	NULL
coordinately	NULL
expressed	NULL
lymphokines	NULL
in	NULL
the	NULL
murine	NULL
T	NULL
lymphoma	NULL
ELA.23	NULL
.	NULL

Blood	NULL
83:3620	NULL
.	NULL

Snijdewint	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
P.	NULL
Kalinski	NULL
,	NULL
E.	NULL
A.	NULL
Wicrenga	NULL
,	NULL
J.	NULL
D.	NULL
Bos	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Kapsenberg	NULL
.	NULL

1993	NULL
.	NULL

Prostaglandin	NULL
E	NULL
;	NULL
differentially	NULL
modulates	NULL
cytokine	NULL
secretion	NULL
profiles	NULL
of	NULL
human	NULL
T	NULL
helper	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:5321	NULL
.	NULL

Arai	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1990	NULL
.	NULL

Cytokines	NULL
:	NULL
coordinators	NULL
of	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

59:783	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
pro-moter	NULL
:	NULL
nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
shared	NULL
by	NULL
three	NULL
lymphokine	NULL
genes-those	NULL
for	NULL
GM-CSF	NULL
,	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
5894	NULL
.	NULL

Siegel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
D.	NULL
H.	NULL
Zhang	NULL
,	NULL
P.	NULL
Ray	NULL
,	NULL
and	NULL
A.	NULL
Ray	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-5	NULL
promoter	NULL
by	NULL
cAMP	NULL
in	NULL
murine	NULL
EL-4	NULL
cells	NULL
requires	NULL
the	NULL
GATA-3	NULL
and	NULL
CLEO	NULL
elements	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:24548	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
76:263	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
,	NULL
T.	NULL
Walunas	NULL
,	NULL
and	NULL
J.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
Avruch	NULL
.	NULL

1996	NULL
.	NULL

Sounding	NULL
the	NULL
alarm	NULL
:	NULL
protein	NULL
kinase	NULL
cascades	NULL
activated	NULL
by	NULL
stress	NULL
and	NULL
inflammation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:24313	NULL
.	NULL

Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Goldsmith	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
MAP	NULL
kinases	NULL
are	NULL
regulated	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14843	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14553	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Li	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
D.	NULL
Whaley	NULL
,	NULL
A.	NULL
Mondino	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1996	NULL
.	NULL

Blocked	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
protein	NULL
kinases	NULL
in	NULL
anergic	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
271:1272	NULL
.	NULL

Hsueh	NULL
,	NULL
Y.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Lai	NULL
.	NULL

1995.	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
but	NULL
not	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
is	NULL
sensitive	NULL
to	NULL
cAMP	NULL
inhibition	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:18094	NULL
.	NULL

Dumont	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
M.	NULL
J.	NULL
Staruch	NULL
,	NULL
P.	NULL
Fischer	NULL
,	NULL
C.	NULL
DaSilva	NULL
,	NULL
and	NULL
R.	NULL
Camacho	NULL
.	NULL

1998	NULL
.	NULL

Inhibition	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
pharmacologic	NULL
disruption	NULL
of	NULL
the	NULL
MEK1/ERK	NULL
MAP	NULL
kinase	NULL
or	NULL
calcineurin	NULL
signaling	NULL
pathways	NULL
results	NULL
in	NULL
differential	NULL
modulation	NULL
of	NULL
cytokine	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2579	NULL
.	NULL

Dong	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
D.	NULL
Yang	NULL
,	NULL
M.	NULL
Wysk	NULL
,	NULL
A.	NULL
J.	NULL
Whitmarsh	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1998	NULL
.	NULL

Defective	NULL
T	NULL
cell	NULL
differentiation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ink1	NULL
.	NULL

Science	NULL
282:2092	NULL
.	NULL

Sugawara	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Moriguchi	NULL
,	NULL
E.	NULL
Nishida	NULL
,	NULL
and	NULL
Y.	NULL
Takahama	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
roles	NULL
of	NULL
ERK	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
pathways	NULL
in	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
9:565	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
J.	NULL
T.	NULL
Laydon	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
T.	NULL
F.	NULL
Gallagher	NULL
,	NULL
S.	NULL
Kumar	NULL
,	NULL
D.	NULL
Green	NULL
,	NULL
D.	NULL
McNulty	NULL
,	NULL
M.	NULL
J.	NULL
Blumenthal	NULL
,	NULL
J.	NULL
R.	NULL
Heys	NULL
,	NULL
S.	NULL
W.	NULL
Landvatter	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
372:739	NULL
.	NULL

Wilson	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
K.	NULL
A.	NULL
Fortner	NULL
,	NULL
D.	NULL
H.	NULL
Lynch	NULL
,	NULL
R.	NULL
R.	NULL
Mattingly	NULL
,	NULL
I.	NULL
G.	NULL
Macara	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Posada	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Budd	NULL
.	NULL

1996	NULL
.	NULL

JNK	NULL
,	NULL
but	NULL
not	NULL
MAPK	NULL
,	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:989	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Enslen	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
M.	NULL
Recht	NULL
,	NULL
T.	NULL
Zapton	NULL
,	NULL
M.	NULL
S.	NULL
Su	NULL
,	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1998	NULL
.	NULL

Interferon-y	NULL
expression	NULL
by	NULL
Th1	NULL
effector	NULL
T	NULL
cells	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:2817	NULL
.	NULL

Hedges	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
M.	NULL
A.	NULL
Dechert	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Yamboliev	NULL
,	NULL
J.	NULL
L.	NULL
Martin	NULL
,	NULL
E.	NULL
Hickey	NULL
,	NULL
L.	NULL
A.	NULL
Weber	NULL
,	NULL
and	NULL
W.	NULL
T.	NULL
Gerthoffer	NULL
.	NULL

1999	NULL
.	NULL

A	NULL
role	NULL
for	NULL
p38	NULL
(	NULL
MAPK	NULL
)	NULL
/HSP27	NULL
pathway	NULL
in	NULL
smooth	NULL
muscle	NULL
cell	NULL
migration	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:24211	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58.	NULL
cAMP	NULL
ACTIVATES	NULL
P38	NULL
MAPK	NULL
IN	NULL
TH2	NULL
CELLS	NULL
Schafer	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
S.	NULL
A.	NULL
Wadsworth	NULL
,	NULL
L.	NULL
Wang	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Sickierka	NULL
.	NULL

1999.	NULL
p38	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
is	NULL
activated	NULL
by	NULL
CD28-mediated	NULL
signaling	NULL
and	NULL
is	NULL
required	NULL
for	NULL
IL-4	NULL
production	NULL
by	NULL
human	NULL
CD4	NULL
``	NULL
*CD45RO	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
Th2	NULL
effector	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:7110	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
V.	NULL
Salojin	NULL
,	NULL
J.	NULL
X.	NULL
Gao	NULL
,	NULL
M.	NULL
J.	NULL
Cameron	NULL
,	NULL
I.	NULL
Bergerot	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Delovitch	NULL
.	NULL

1999.	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
mediates	NULL
signal	NULL
integration	NULL
of	NULL
TCR/CD28	NULL
costimulation	NULL
in	NULL
primary	NULL
murine	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3819	NULL
.	NULL

Livingstone	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Patel	NULL
,	NULL
and	NULL
N.	NULL
Jones	NULL
.	NULL

1995	NULL
.	NULL

ATF-2	NULL
contains	NULL
a	NULL
phosphorylation-dependent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1785	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
J.	NULL
Whitmarsh	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1996	NULL
.	NULL

MKK3-	NULL
and	NULL
MKK6-regulated	NULL
gene	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1247	NULL
.	NULL

Wang	NULL
,	NULL
X	NULL
.	NULL

Z.	NULL
,	NULL
and	NULL
D.	NULL
Ron	NULL
.	NULL

1996	NULL
.	NULL

Stress-induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
CHOP	NULL
(	NULL
GADD153	NULL
)	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

Science	NULL
272	NULL
:	NULL
1347	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Y.	NULL
Jiang	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
V.	NULL
V.	NULL
Kravchenko	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEFZC	NULL
by	NULL
the	NULL
MAP	NULL
kinase	NULL
p38	NULL
in	NULL
inflammation	NULL
.	NULL

Nature	NULL
386:296	NULL
.	NULL

Rouse	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
S.	NULL
Trigon	NULL
,	NULL
M.	NULL
Morange	NULL
,	NULL
A.	NULL
Alonso-Llamazares	NULL
,	NULL
D.	NULL
Zamanillo	NULL
,	NULL
T.	NULL
Hunt	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Nebreda	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
that	NULL
stimulates	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Celf	NULL
78:1027	NULL
.	NULL

McLaughlin	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
S.	NULL
Kumar	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
S.	NULL
Van	NULL
Hom	NULL
,	NULL
J.	NULL
C.	NULL
Lee	NULL
,	NULL
G.	NULL
P.	NULL
Livi	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Young	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase-activated	NULL
protein	NULL
kinase-3	NULL
,	NULL
a	NULL
novel	NULL
substrate	NULL
of	NULL
CSBP	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8488	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
L.	NULL
Cohn	NULL
,	NULL
P.	NULL
Ray	NULL
,	NULL
K.	NULL
Bottomly	NULL
,	NULL
and	NULL
A.	NULL
Ray	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
murine	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
and	NULL
controls	NULL
Th2-specific	NULL
expression	NULL
of	NULL
the	NULL
interleukin-5	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21597.	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
L.	NULL
Yang	NULL
,	NULL
L.	NULL
Cohn	NULL
,	NULL
L.	NULL
Parkyn	NULL
,	NULL
R.	NULL
Homer	NULL
,	NULL
P.	NULL
Ray	NULL
,	NULL
and	NULL
A.	NULL
Ray	NULL
.	NULL

1999	NULL
.	NULL

Inhibition	NULL
of	NULL
allergic	NULL
inflammation	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
asthma	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
GATA-3	NULL
.	NULL

Immunity	NULL
11:473	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1993.	NULL
cAMP	NULL
activates	NULL
the	NULL
IL-5	NULL
promoter	NULL
synergistically	NULL
with	NULL
phorbol	NULL
ester	NULL
through	NULL
the	NULL
signaling	NULL
pathway	NULL
involving	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
mouse	NULL
thymoma	NULL
line	NULL
BL-4	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6135	NULL
.	NULL

Tamir	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Granot	NULL
,	NULL
and	NULL
N.	NULL
Isakov	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
by	NULL
cAMP	NULL
is	NULL
associated	NULL
with	NULL
down-regulation	NULL
of	NULL
two	NULL
parallel	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
,	NULL
the	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:1514	NULL
.	NULL

Hale	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
D.	NULL
Trollinger	NULL
,	NULL
M.	NULL
Rihanck	NULL
,	NULL
and	NULL
C.	NULL
L.	NULL
Manthey	NULL
.	NULL

1999	NULL
.	NULL

Differential	NULL
expression	NULL
and	NULL
activation	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
a	NULL
,	NULL
B	NULL
,	NULL
y	NULL
,	NULL
and	NULL
8	NULL
in	NULL
inflammatory	NULL
cell	NULL
lineages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:4246	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
L.	NULL
Yang	NULL
,	NULL
and	NULL
A.	NULL
Ray	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-5	NULL
and	NULL
IL-4	NULL
genes	NULL
to	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3817	NULL
.	NULL

Lacour	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Arrighi	NULL
,	NULL
K.	NULL
M.	NULL
Muller	NULL
,	NULL
C.	NULL
Carlberg	NULL
,	NULL
J.	NULL
H.	NULL
Saurat	NULL
,	NULL
and	NULL
C.	NULL
Hauser	NULL
.	NULL

1994.	NULL
cAMP	NULL
up-regulates	NULL
IL-4	NULL
and	NULL
IL-5	NULL
production	NULL
from	NULL
activated	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
while	NULL
decreasing	NULL
IL-2	NULL
release	NULL
and	NULL
NF-AT	NULL
induction	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1333	NULL
.	NULL

Skalhegg	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
B.	NULL
F.	NULL
Landmark	NULL
,	NULL
S.	NULL
O.	NULL
Doskeland	NULL
,	NULL
V.	NULL
Hansson	NULL
,	NULL
T.	NULL
Lea	NULL
,	NULL
and	NULL
T.	NULL
Jahnsen	NULL
.	NULL

1992	NULL
.	NULL

Cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
type	NULL
I	NULL
mediates	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
3',5	NULL
``	NULL
-cyclic	NULL
adenosine	NULL
monophosphate	NULL
on	NULL
cell	NULL
replication	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:15707	NULL
.	NULL

Kammer	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
I.	NULL
U.	NULL
Khan	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kammer	NULL
,	NULL
I.	NULL
Olorenshaw	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1996	NULL
.	NULL

Deficient	NULL
type	NULL
I	NULL
protein	NULL
kinase	NULL
A	NULL
isozyme	NULL
activity	NULL
in	NULL
systemic	NULL
lupus	NULL
erythema-tosus	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2690	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Lee	NULL
,	NULL
L.	NULL
Bibbs	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265:808	NULL
.	NULL

Freshney	NULL
,	NULL
N.	NULL
W.	NULL
,	NULL
L.	NULL
Rawlinson	NULL
,	NULL
F.	NULL
Guesdon	NULL
,	NULL
E.	NULL
Jones	NULL
,	NULL
S.	NULL
Cowley	NULL
,	NULL
J.	NULL
Hsuan	NULL
,	NULL
and	NULL
J.	NULL
Saklatvala	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-1	NULL
activates	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
cascade	NULL
that	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
Hsp27	NULL
.	NULL

Cell	NULL
78:1039	NULL
.	NULL

Mertens	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Craxton	NULL
,	NULL
and	NULL
M.	NULL
Goedert	NULL
.	NULL

1996	NULL
.	NULL

SAP	NULL
kinase-3	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
family	NULL
of	NULL
mammalian	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

383:273	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Chen	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
W.	NULL
Guo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gegner	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Han	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
p38B	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:17920	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
E.	NULL
M.	NULL
Schwarz	NULL
,	NULL
A.	NULL
Lin	NULL
,	NULL
K.	NULL
Guan	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.	NULL
Han	NULL
.	NULL

1997	NULL
.	NULL

Structure-function	NULL
studies	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
:	NULL
loop	NULL
12	NULL
influences	NULL
substrate	NULL
specificity	NULL
and	NULL
autophosphorylation	NULL
,	NULL
but	NULL
not	NULL
upstream	NULL
kinase	NULL
selection	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:11096	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Alonso	NULL
,	NULL
N.	NULL
Morrice	NULL
,	NULL
M.	NULL
Jones	NULL
,	NULL
R.	NULL
Meier	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Nebreda	NULL
.	NULL

1996	NULL
.	NULL

Purification	NULL
and	NULL
cDNA	NULL
cloning	NULL
of	NULL
SAPKK3	NULL
,	NULL
the	NULL
major	NULL
activator	NULL
of	NULL
RK/p38	NULL
in	NULL
stress-	NULL
and	NULL
cytokine-stimulated	NULL
monocytes	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4156	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Goedert	NULL
,	NULL
M.	NULL
Craxton	NULL
,	NULL
R.	NULL
Jakes	NULL
,	NULL
and	NULL
P.	NULL
Cohen	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
novel	NULL
MAP	NULL
kinase	NULL
homologue	NULL
SAPK4	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stresses	NULL
is	NULL
mediated	NULL
by	NULL
SKK3	NULL
(	NULL
MKK6	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

25:5569	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Goedert	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
M.	NULL
Craxton	NULL
,	NULL
R.	NULL
Jakes	NULL
,	NULL
and	NULL
P.	NULL
Cohen	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
novel	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
SAPK4	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stresses	NULL
is	NULL
mediated	NULL
by	NULL
SKK3	NULL
(	NULL
MKK6	NULL
)	NULL
:	NULL
comparison	NULL
of	NULL
its	NULL
substrate	NULL
specificity	NULL
with	NULL
that	NULL
of	NULL
other	NULL
SAP	NULL
kinases	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3563	NULL
.	NULL

Wang	NULL
,	NULL
X.	NULL
S.	NULL
,	NULL
K.	NULL
Diener	NULL
,	NULL
C.	NULL
L.	NULL
Manthey	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
B.	NULL
Rosenzweig	NULL
,	NULL
J.	NULL
Bray	NULL
,	NULL
J.	NULL
Delaney	NULL
,	NULL
C.	NULL
N.	NULL
Cole	NULL
,	NULL
P.	NULL
Y.	NULL
Chan-Hui	NULL
,	NULL
N.	NULL
Mantlo	NULL
,	NULL
H.	NULL
S.	NULL
Lichenstein	NULL
,	NULL
M.	NULL
Zukowski	NULL
,	NULL
and	NULL
Z.	NULL
Yao	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:23668	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Brady	NULL
,	NULL
M.	NULL
X.	NULL
Yang	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Barbosa	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
MEK6	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
cascade	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:11427	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
R.	NULL
J.	NULL
Gum	NULL
,	NULL
A.	NULL
T.	NULL
Hand	NULL
,	NULL
J.	NULL
C.	NULL
Lee	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Young	NULL
.	NULL

1997	NULL
.	NULL

Novel	NULL
homologues	NULL
of	NULL
CSBP/p38	NULL
MAP	NULL
kinase	NULL
:	NULL
activation	NULL
,	NULL
substrate	NULL
specificity	NULL
and	NULL
sensitivity	NULL
to	NULL
inhibition	NULL
by	NULL
pyridinyl	NULL
imidazoles	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

235:533	NULL
.	NULL

Zheng	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89:587	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

5605	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1998	NULL
.	NULL

Characterization	NULL
of	NULL
cis-	NULL
regulatory	NULL
elements	NULL
and	NULL
nuclear	NULL
factors	NULL
conferring	NULL
Th2-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
:	NULL
a	NULL
role	NULL
for	NULL
a	NULL
GATA-binding	NULL
protein	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2343	NULL
.	NULL

Ranganath	NULL
,	NULL
S.	NULL
,	NULL
W.	NULL
Ouyang	NULL
,	NULL
D.	NULL
Bhattarcharya	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
A.	NULL
Grupe	NULL
,	NULL
G.	NULL
Peltz	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1998	NULL
.	NULL

GATA-3-dependent	NULL
enhancer	NULL
activity	NULL
in	NULL
IL-4	NULL
gene	NULL
regu-lation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3822	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proto-oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
85:973	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
c-Maf	NULL
controls	NULL
the	NULL
production	NULL
of	NULL
interleukin-4	NULL
but	NULL
not	NULL
other	NULL
Th2	NULL
cytokines	NULL
.	NULL

Immunity	NULL
10:745	NULL
.	NULL

Crossley	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:16589	NULL
.	NULL

Towatari	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
E.	NULL
May	NULL
,	NULL
R.	NULL
Marais	NULL
,	NULL
G.	NULL
R.	NULL
Perkins	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
S.	NULL
Cowley	NULL
,	NULL
and	NULL
T.	NULL
Enver	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
GATA-2	NULL
phosphorylation	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
and	NULL
interleukin-3	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4101	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

